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Chapter One The History of the Strobilurin Family 
1.1 Background on the strobilurin family 
With the earth's popUlation growing at a great rate, ways to increase the yields of 
plant matter from commercial horticulture are needed. A variety of methods have been 
investigated towards this end. Many of these methods have considerable associated 
risks. 'T'he genetic engineering of higher-yielding crops or the extensive use of 
feliilisers are two examples of this. One method which is often overlooked is the use 
of pesticides or fungicides to minimise the deleterious effects that plant pathogens 
have on crops. The fungal kingdom contains many members which are pathogenic to 
plants and as such, treatment of fungal infestations using commercial fungicides was a 
US$6 billion industry in 1996.1 
One of the principal difficulties with the use of commercial fungicides is the 
development of wide-spread fungal resistance to their cytotoxic effects. The best 
method for countering this rcsistance is to develop new classes of fungicides with 
novel modes of action. Their judicious use would then offer a solution to the 
increasingly wide-spread problem of fungicidal resistance. l However, the 
development of an entirely novel class of fungicide is a rare event. Most new 
ftmgicides involve structural variation of previously used cytotoxins and therefore 
have limited use in the alleviation of fungal resistance. 
In 1996, both BASF and Zeneca (now Astra-Zeneca) independently released 
fungicides which had an entirely novel mode of action. Azoxystrobin (BASF) and 
kresoxim methyl (Zeneca) inhibit fungal respiration on an enzymatic leveL They were 
developed from a class of fungal-derived natural products known as the strobilurins. 
These are cytotoxic derivatives of p-methoxyacrylic acid and are characterised by the 
presence of an arene ring connected to a triene system, which terminates in a p-
methoxymethacrylate unit as shown in Figure 1.1. The sales of azoxystrobin 
projected to peak at US$500 million dollars, I and as such the represent an important 
new class of commercial fungicide. 
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Figure 1.1 - A generalised structure of the strobilurin family. RI , R2, R3, and R4 
indicate Imown points of substituent variation. 
The history of the strobilurin family begins with the work of Steglich and Anke, who 
in 1976 initiated a program aiming at isolating antibiotic agents from the fungal class 
basidiomycetes. The basidiomycetes class had not previously been studied to any 
degree as they are difficult to culture, in contrast to other fungal classes.2 The first 
publication from this collaboration detailed the isolation of strobilurin A (1.1) from 
the mycelium of the basidiomycetes Strobiluris tenacellus.2 This compound possessed 
powerful antibiotic activity against a range of eukaryotic cells. Strobilurin A was 
found to have significant similarities to the antifungal antibiotic mucidin, whose 
biological activities and structural data were published by a Czech group in 1969/ and 
patented in 1970,4 without any structure being proposed. The only discrepancy 
between the spectroscopic data of strobilurin A and those of mucidin was the optical 
activity reported for mucidin. This clearly ruled out a common identity with 
strobilurin A, as strobilurin A contains no stereochemical elements. Steglich and Anke 
made an attempt to establish the structure of Mucidin by re-isolating it from the 
basidiomycete Oudemansiella mucida.5 This provided two materials - strobilurin A 
and the optically-active oudemansin A (1.2). Determining the stereochemistry of the 
triene system of strobilurin A also posed difficulties. In their original paper,2 Steglich 
and Anke reported the stereochemistry as being (E,E,Ej as shown. Initial synthetic 
work indicated that the triene stereochemistry was more likely to be (E,Z,E).5 This 
proposal was eventually confirmed by a synthesis starting from materials of known 
stereochemical configuration (see Section 1.4),6 
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After protracted study of the Czech patent literature, combined with direct 
spectroscopic comparison, it was determined that mucidin and strobilurin A were in 
fact the same compound. The optical activity attributed to mucidin was ascribed to a 
"printing error". 5 
After the isolation of strobilurin A, the groups of Steglich and Anke continued with 
their program of investigating the isolation of anti-fungal agents from basidiomycetes. 
In the following years, a wide range of strobilurins have been isolated by their group, 
as well as by other groups. An additional 13 strobilurins have been isolated to date, 
and these are shown in Figure 1.2. 7 
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Figure 1.2 The natural strobilurins 
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As can be seen, the common structural features of these compounds are an arene 
substituted with a triene with a p-methoxyacrylate system at its terminus. However, 
these compounds display considerable variation in the substituents present on the 
arene ring and to lesser degree, variation in functionality present on the triene system. 
The type of functionalisation on the arene ranges from the simple isopentenyl ethers 
of strobilurins F and C, to the dioxepin ring system of strobilurins D and K. The triene 
system shows comparatively little variation, with only carbons 9 (methyl ether), or 13 
(hydroxyl group) varying in their substitution. The oudemansins are a closely related 
group of compounds which have been isolated from the same fungi as the 
strobilurins.8 They display similar toxicity profiles, with the only structural difference 
being that the Sp2 carbons 9 and lOin the strobilurins are now Sp3 centres in the 
oudemansins, with carbon-9 bearing a methoxy substituent. This similarity, combined 
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with their common occurrence suggests that the oudemansins share a common 
biosynthetic ancestry to the 9-methoxystrobilurins.7 
OMe 
Oudemansin A Oudemansin L 
Oudemansin B 
Oudemansin X I 2 R =H, R =OCH3 
1.2 Biological Activity of the Strobilurins 
The fungi which produce the strobilurins have a world-wide distribution. 7 A variety of 
these fungi have been shown to produce sufficient quantities of the strobilurins to 
inhibit growth of other fungal species when cultivated in conditions mimicking the 
strobilurin-producing fungus' natural environment.9 This suggests that the presence of 
the strobilurins confers a competitive advantage to their producers, by preventing 
other fungal species from growing on the same substrate. 
Soon after the isolation of strobilurin A, Steglich and Anke's groups showed that its 
cytotoxicity was due to the inhibition of eukaryotic respiration. [0 Although protein, 
RNA and DNA synthesis were also inhibited, this was attributed to the resultant 
deficit in intracellular ATP.5 The strobilurins and oudemansins were shown to inhibit 
the cytochrome bc I complex present in the inner mitochondrial membrane of fungi 
and other eukaryotes. IO,]] This enzyme complex catalyses the transfer of electrons 
from the lipid-soluble carrier ubiquinol to the water-soluble acceptor cytochrome c. 
Concomitant with this, protons are translocated across the mitochondrial membrane. 
This establishes the proton gradient which drives ATP generation.5 The strobilurins 
share their inhibitory mode of action with the oudemansins and the myxothiazols, 
another class of fungal metabolite whose general form is shown in Figure 1.3. 
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Figure 1.3 The general structure of the myxothiazol family, a class of respiratory 
inhibitor. 
strobilurins, the oudemansins and the myxothiazols are all derivatives of (E)-~­
methoxyacrylic acid. This moiety is the "toxophore", that is the constituent which 
gives these metabolites their cytotoxic activity.12 The (E)-~-methoxyacrylic acid 
moiety reversibly binds to the heme centre of the ubihydroquinone oxidation centre 
(Qo) on cytochrome b. 11 Through a combination of genetic13 and X-ray 
crystallographic studies, I! it has been foutld that this binding results in a conformation 
restriction of the cytochrome bc complex. This slightly displaces ubiquinol from its 
binding site. 12 and prevents the transfer of electrons from cytochromes b and cl • 
Hence, respiration is prevented. 
Only (E)-~-methoxyacrylic acid-derivatives display any significant cytotoxicity, with 
the (2) isomers not being cytotoxic. 14 Molecular orbital calculations have established 
that the minimum energy conformation for the natural (E,Z,E) triene has the planar 
phenylpentadienyl and ~-methoxyacrylate groups positioned orthogonally to one 
another. 14,15 The synthetic (all-E) isomer adopts a radically different shape and cannot 
efficiently bind the cytochrome bCI centre. Calculations showed the oudemansins 
adopt a similar minimum energy conformation to that of the strobilurins, despite the 
f1exibility imparted by the two Sp3 centres adjacent to the ~-methoxyacrylate group.15 
Obviously, tl1e fungi which produce the strobilurins and other related respiratory-
inhibitors have an inbuilt resistance to their cytotoxic effects. The mode of resistance 
has been shown to involve mutation of the ubiquinol binding site on the cytochrome b 
protein. 13 This mutation involves the substitution of a small an1ino acid (alanine) for a 
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larger amino (generally isoleucine) at position 127 of the binding envelope of the 
reduced ubiquinol moiety. The steric bulk at this position hinders the binding of the 
strobilurins and oudemansins, but not that of ubiquinol. 13 This mutation was found 
across a wide range of strobilurin- and oudemansin-producing fungi. 
1.3 - The strobilurins as lead compounds for fungicide developmentt 
Soon after Steglich and Anke's group first isolated strobilurin A,2 it was tested at the 
National Cancer Institute for potential antitumour activity. While it displayed no acute 
toxicity in the tumour-bearing mice, it had only weak antitumour activity.9 This ruled 
out its development as an anti-cancer agent However, there are four main 
characteristics lead compounds for fungicide development must display: 
• High fungal cytotoxicity 
<I' Low toxicity to humans 
<I' A novel mode of action 
III A structurally-simple toxophore. 
The strobilurins demonstrate all these characteristics and as such, they quickly drew 
the attention of agrochemical companies. 'The two main companies involved in the 
development of commercial fungicides based on the strobilurins are BASF and 
Zeneca (now Astra-Zeneca). In 1982 Zeneca obtained a sample of myxothiazol from 
Anke's group and trialed it in a standard greenhouse assay for fungicidal activity, 
where it performed admirably. However, when strobilurin A was trialed, it was 
essentially inactive against a range of fungi growing on whole plants in a greenhouse 
triaL This was in stark contrast to the high activity it displayed in a variety of in vitro 
assays. It was eventually determined its inactivity was due to a combination of 
photochemical degradation and loss through volatilisation.13 In 1983 BASF entered 
i Due to the commercial sensitivity associated with fungicide development, only one comprehensive 
review of the development of azoxystrobrin and kresoxim methyl has been published. The information 
in this section is sourced from Sauter, H.; Steglich, W.; Anke, T.; Angell'. Chem. Int. Ed 1999, 38, 
1328-1349. 
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the field with trials of strobilurin A and encountered similar difficulties with a low 
activity against a range of fungi in greenhouse trials. 
The extreme photolability of strobilurin A effectively mled out its use as a fungicide. 
However, it was clear that the p-methoxyacrylate moiety imparted significant 
antifungal activity. Based on the efficacy of oudemansin in greenhouse trials it was 
clear that the p-methoxyacrylate moiety was not susceptible to photochemical 
cleavage. Thus, attention was focussed on creating analogues which retained the 
toxophore, while having greater photochemical stability. 
Both the BASF and Zeneca groups quickly arrived at the stilbene stmcture 1.4. The 
middle olefin in the triene system is locked by forming a ring. This proved to have 
higher activity in greenhouse tests, but was still subject to some photochemical 
breakdown. 
CI 
~ OMe 
1.4 
More stable variants of this core stmcture were prepared (1.5 and 1.6). These gave 
vast improvements in both greenhouse activity and photostability. 
~£I O ~ 
::::::.... OMe 
Me02C 
1.7 
The key compound for the Zeneca team was the diphenyl ether 1.7, which showed 
high photochemical stability, high activity in greenhouse trials and a broad range of 
antifungal activity. Additionally, it displayed systemic transport capabilities in plants, 
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which meant that it was readily solubilised and transported throughout the plants. This 
allowed more effective treatment at lower dosages. However, this was coupled with 
low level toxicity to some target plant species. Phenyl ether 1.7 formed the basis for a 
patent application filed by the Zeneca group in October 1984.15 This covered a wide 
range of substituted arenes coupled to a ~-methoxyacrylate group. This patent 
application preceded the earliest patents filed by BASF, by six months.16a-d These 
patents were broad enough to prevent further work by BASF on the ~­
methoxymethacrylates as a basis for fungicide development. Thus, the research group 
at Zeneca continued with the refinement of the carrier group for delivering the ~­
methoxymethacrylate group. 
The BASF group was forced to find a way around the tight confines of Zeneca's 
patents. The only loophole in the patents was in the variation of the actual 
phatmacophore. Thus, they began a search for new target species which could adopt 
conformations isosteric to those of the ~-methoxyacrylates. The ~-methoxyacrylamide 
moiety seen in the myxothiazol class clearly demonstrates that variation in the 
substituents present on the toxophoric unit does not destroy activity. Another BASF 
group had previously conducted work in this area and found that oxime ethers of 
general type 1.8 and 1.9 showed considerable greenhouse activity. A patent was 
quickly filed. 17 The Zeneca team had also been working on oxime ether-type 
fungicides. Ironically, their patent application on this type of compound was filed 
only two days after that of the BASF team! 18 An in vitro test was developed which 
measured the strength of docking between a cytotoxin and the cytochrome bc 
complex. This test showed that oxime ethers of general type 1.8 were around ten times 
more active than the isomeric class 1.9 in a wide range of in vitro tests. Such a result 
would be less clear in a greenhouse test, which contain more independent variables 
and often give less precise results. 
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By early 1990, both the BASF and Zeneca teams had lead compounds which 
contained a viable toxophore and a general carrier structure. Both teams now turued 
their attention to the optimisation of the carrier portion. The Zeneca team focussed on 
the development of a carrier which allowed systemic transport of the fungicide, 
without any associated phytotoxicity. It was eventually found that a hetereoatom 
configuration like that in triaryl ether 1.10 optimised these two requirements. 
1.10 
Compound 1.10 showed an excellent cytotoxicity profile, systemic transport 
capabilities, and little associated phytotoxicity. It was named azoxystrobin and was 
first released onto the market in February 1996. 
The BASF team had a somewhat shorter route to a commercially-viable fungicide. 
Aryl ether 1.11 gave an optimal balance of high fungicidal performance, combined 
with a cost-effective synthesis. Compound 1.11 was named laesoxim-methyl and was 
released onto the market in 1996, a few days before the release of azoxystrobin. Given 
the large number of strobilurin-producing fungi, it was clear that fungal species 
targeted by azoxystrobin or laesoxim methyl could, in time, develop resistance to 
their cytotoxic activities. To this end, both fungicides were sold as a mixture with 
other fungicides, to minimise the chance of mutations affording fungicidal resistance. 
Me ~I ~O ~ U :::,... ",OMe 
Me02C N 
1.11 
Chapter One The History of the Strobilurin Family 11 
Two other compames have subsequently joined the race to develop commercial 
fungicides. Shinogi released the oxime-ether metominostrobin onto the Japanese 
market in 1998, primarily for the treatment of rice diseases. 
Novmiis (formerly Ciba-Giegy) have developed the oxime ether trifloxystrobin 
(1.12), which is currently in the process of registration in the USA. 
1.4 Previous synthetic work on the strobilurins 
A large amount of synthetic chemistry has been undertaken with the mm of 
developing fungicides based around the strobilurin nucleus. However, comparatively 
little work has been performed on syntheses of members of the strobilurin family 
themselves. To date, total syntheses of strobilurins A, B, and E have been achieved. 
Most attention has focussed on strobilurin A due to its simplicity and role in fungicide 
development. The first synthesis was carried out by Steglich and Anke's group to try 
to confirm their proposed all-(E) stereochemical assignment for the triene system (see 
Scheme 1.1),9,20 E-Cinnamaldehyde was coupled with the enol ate of 2-ketobutyric 
acid to give diene 1.13. This was converted to the methacrylate ester and the resultant 
trienoate subjected to photoisomerisation. 
~CHO 
V 
+ I. 
1.13 
ii.-iv. ~Me 
V .'~r\ ('~oMe Me02C 
1.1 
Reagents - i) KOH, ii) SOCI 2, MeOH, 
iii) Ph3PCH20Me iv) hv 
Scheme 1.1 - Steglich and Anke's synthesis of strobilurin A 
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Originally, the authors thought that the initial alkylation had given diene 1.14 and that 
this species required isomerisation to form the desired all-(E) isomer.19 
~Me 
V Ko2c A O 
1.14 
In fact, the alkylation had gIven diene 1.13, which when subjected to 
photoisomerisation gave the (E,Z,E)-triene. The nmr data of which concurred with 
that of the natural product. These errors were subsequently corrected by the authors, 
when they republished the synthesis, with the correct stereochemical assignments.2o 
The first stereo-controlled synthesis of strobilurin A (Scheme 1.2) was carried out by 
the Zeneca group during their development of azoxystrobin. 14,15 The (Z,E)-dienoate 
1.15 was chosen as the starting material. As all four possible isomers had been 
characterised, its configuration could be assigned with certainty. Dienoate 1.15 was 
converted to dienol 1.16, via conversion to the aldehyde and addition of 
tris(thiomethyl)lithium. Methanolysis, to give the methyl ester, was followed by 
oxidation to the ketone 1.17. Reaction of methoxymethyltriphenylphosphorane with 
ketone 1.17 gave strobilurin A (1.1). This was achieved in 9.2% overall yield from the 
dienoate 1.15. 
~Me V C02E! 
1.15 
i, ii, iii 
)I> 0~Me V HoAC(SMeh 
1.16 
I({'non)!" - i) LiAIH4 ; ii) Mn02 iii) Li(C(SMeh) 
iv) HgO, MeOH/H20 (35% over four steps) 
v) Mn02' vi) Ph,PCHOMe (26% over two steps) 
v 
~Me 
V .. on("'~OMe Me02C 
1.1 
strobilurin A 
Scheme 1.2 - Clough et al. 's stereo-controlled synthesis of strobilurin A 
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Strobilurin B (1.18) was synthesised by Sutter working at Ciba-Giegy (now Novartis) 
as detailed in Figure 1.19 .21 
Me°xy::~XMe 
I ~ OMe 
CI ,,-:;::; Me02C 
1.18 
strobilurin B 
The phosphonium salt 1.19 was formed via a sequence of alkylation, radical 
bromination and phosphine addition starting from 2-chloro-4-methylphenoL The 
chain was extended using Wittig chemistry. The reaction of phosphonium salt 1.19 
with the acetal-protected butyraldehyde 1.20 gave a 1: 1 mixture of the E and Z 
isomers of the alkene. l11is acetal was deprotected to give an isomeric mixture of 
ketone 1.22. This ketone was subjected -to another Wittig coupling with phosphorane 
1.21 to give dienoate 1.23. This was formylated at the a-position relative to the ester. 
Ester 1.23 was enolised, and the resultant enol O-methylated, to give the p-
methoxymethaerylate moiety and thus, the complete triene system. As there is a 1: 1 
mixture formed in step iv), the overall yield of the desired (E,Z,E) isomer was only 
4.5% ; in addition to an equal amount of the all-E isomer. 
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i), ii), iii) 
... 
45% 
OM~Me 
CI~ ~COOCH3 
1.23 
vn. v;;) ~ 80% 
strobliurin B 
1.18 
I PPh3 Bf Me0X)' + 
CI ...7 
+ 1\ o 0 ~CHO 
v) 
80% 
1.19 1.20 
;v) ~ 52% 
o 
MeO~Me + 
CI~ 0 
JL ,PPh3 
MeO' 'I 
Me 
1.22 1.21 
1 : 1 mixture of isomers 
Conditions - i) (CH30hS02' K2C03, ii) NBS,AIBN, 
iii) P(C6BSh iv) KatBu, v) toluene, reflux, 
vi) HCOOCB3, NaB, vii) (CH30hS02' K2C03. 
Scheme 1.3 - Sutter's synthesis of strobilurin B 
The only other total synthesis of a strobilurin that has been completed is Steglich and 
Anke's synthesis of the stl1lcturally-complex strobilurin E (1.24).22 
strobilurin E 
1.24 
The distinguishing structural feature of this strobilurin is the spiroacetal ring system 
adjoined to the arene ring. Clearly, a synthetic approach was required which avoided 
acidic conditions after the spiroacetal was fonned. In Steglich and Anke's synthesis 
(shown in Scheme 1.4), the spiro acetal was constl1lcted in two steps. 3,4-
Dihydroxybenzaldehyde was alkylated, using bromoketone 1.25, to give the desired 
six-membered ring hemiacetal 1.26, with the appropriate regiochemistry. The 
tetrahydropyran protecting group was removed and the resultant diol reacted with 3-
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methylbutenal under acid catalysis to give the desired spiroacetal1.27 in 57% yield, 
along with 43% of the diastereomeric spiro acetal 1.28. 
Steglich and Anke's approaeh to the triene system centred around the use of Wittig-
type homologations to extend the carbon skeleton. Non-stabilised phosphoranes were 
used so as to favour the formation of the E-olefin. The first olefinic unit was formed 
via the reaction of spiroacetal 1.27 with fonnylmethylenetriphenylphosphorane to 
give the desired enal in 36% yield. This enal was converted to dienoate 1.29 in 86% 
yield via another Wittig homologation. Finally, the p-methoxyacrylate was installed 
via a Wittig reaction of dienoate 1.29 with methoxytriphenylphosphorane to give the 
all-(E) stereoisomer. This material was then photoisomerised in 80% yield to give the 
correct (E,Z,E) stereochemistry. 
OTHP 
~Br + 
o 
1.25 
1.29 
H 
strobilurin E 
1.24 
HO~CHO __ i)-B)Ioo __ 
HO~ 57% 
iii), iv) 
<OIl( 
31% 
i ) K2C03, ii) 3-methylbutenal, cat. PPTS, 
iii) Ph3PCHCHO, iv) Ph3PCHOCH3 
THPO OH 
Me-t---i'\\\°JC(CHO Me~ 1# 
o 
1.26 
il) ~ 57% 
ot 
Me-+--l\\°JC(CHO Me~ 1# 
o 
1.27 
~+ 
O~O 
t.t~0JC(CHO Me ,\ " Me I # o 
1.28 
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Scheme 1.4 - Key steps in Steglich and Anke's synthesis of strobilurin E 
This synthesis highlights the difficulties associated with the use of the Wittig 
methodology for developing the tfiene system of the strobilurins. Although the 
(E,E,E)- triene system was able to be elaborated without disrupting the spiro acetal, the 
three Wittig reactions proceeded in a combined yield of only 11.1 %. Principally, this 
is as a result of the low-yields of the desired E isomer during the Wittig reactions. 
1.5 The structural revision of strobilurins K and D 
Recent work at the University of Canterbury has centred around the isolation of 
biologically-active natural products from New Zealand terrestrial fungi?3 In 1994 the 
basidiomycete Favolaschia calocera was investigated as part of an M.Sc thesis. It was 
found to contain a isoprenoid-derived cytotoxic product, which was named 9-
methoxystrobilurin L and assigned structure 1.30. There were two crucial pieces of 
evidence which supported this putative structure; an HMBC correlation seen from C-
to H-18, and an nOe correlation from C-21 to C-22 to C-l on the aromatic ring. 
~l 0 __ /;2 0 ~ 0 18 o Me02e 
9-methoxy strobilurin L 
1.30 
Me 
Figure 1.4 - Nicholas et ai.'s proposed structure for 9-methoxystrobilurin L 
Concmrent with this work, Steglich's group. published an account detailing the 
isolation of 9-methoxystrobilurin K from an unidentified Ethiopian fungus of the 
Favolaschia genus. 24 HREIMS analysis, combined with extensive two-dimensional 
I1mr analysis, led to 9-methoxystrobilurin K being assigned structure 1.31. 
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OMe 
9-methoxystrobilurin K 
1.31 
Me 
:::::..... OMe 
Figure 1.5 Steglich et ai's proposed structure for 9-methoxystrobilurin K, 
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In 1996 Wood et at investigated Ethiopian fungus Favolaschia pustulosa and 
reported the new strobilurin 9-methoxystrobilurin L (1.32)?5 
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Figure 1.6 - Wood et al. 's proposed structure for 9-methoxystrobilurin L 
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The spectroscopic data for both of these compounds were found to be identical to 
those of the compound isolated by Nicholas et al. at the University of Canterbury. 
Clearly, two of the proposed structures were incorrect. Two-dimensional nmr studies 
carried out by Nicholas et al. allowed them to discount Wood proposed structure. 
When an HMBC experiment was performed upon their sample in CDCI3, a correlation 
was seen from HI8to C22. This correlation effectively ruled out Wood proposed 
dioxane structure (1.32). Wood had performed their HMBC experiments in MeOD. 
When this was repeated by Nicholas et al., the key correlation from HI8 to C22 was 
not observed due to the presence of an overlapping T) noise ridge. This meant that 
either Nicholas's, or Steglich's proposed structure of 9-methoxystrobilurin K was the 
correct one. 
In an thorough piece of follow-up work,27 Nicholas et al. conclusively proved that 
their proposed benzodioxepin structure 1.30 was the correct structure of 9-
methoxystrobilurin K, and that 9-methoxystrobilurin K and 9-methoxystrobilurin L 
were the same compound. This was achieved by preparing a model system of their 
proposed benzodioxepin structure (1.33) and a model of Steglich et al. ' s proposed 
structure (1.34). The preparation of these model fragments will be discussed further in 
Chapter 2. 
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Figure 1.7 - Model fragments of the two possible structures of 9-methoxystrobilurin 
K 
The 'H and Uc 11mr data for fragment 1.33 were inconsistent with those published for 
the natural product. Principally, the epoxide carbons in 1.33 gave significantly 
different chemical shifts from those observed in the 13C spectrum of the natural 
product. Contrastingly, fragment 1.34 gave lH and l3C rum data which were consistent 
with those observed in the natural product. This finding, combined with the previous 
nmr-based arguments, indicated that the correct structure for 9-methoxystrobilurin K 
was 1.30. 
Nicholas et al. proposed that the structures of strobilurin D (1.35f8 and 
hydroxystrobilurin D (1.36)29 were also incorrect Both had previously been assigned 
the epoxyprenyl structure shown in 1.33. Inspection of their lH and l3C data suggested 
that the benzodioxepin ring system was present 
strobilurin D X=H 1.35 
hydroxystrobilurin D X=OH 1.36 
X 
OMe 
Concurrent with the work discussed in this thesis, Steglich and Anke's group 
published a paper detailing the isolation, structural assignment and stereochemistry of 
strobilurin I (1.37).30 
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The triene system was degraded by ozonolysis to give the corresponding 
benzodioxepin carbaldehyde l.4L 8tereoselective syntheses of both the R and 8-
enantiomers of this moiety allowed the confirmation of the stereochemistry of the 
natural product. 
:{
0X)CHO 
HO I 
# 
o 
1.41 
Cinnamate 1.38 was obtained from ethyl 3,4-dihydroxycinnimate via alkylation and 
epoxidation. The benzodioxepin was formed by a Lewis acid-catalysed cyclisation of 
cilmamic acid derivative 1.38, which proceeded in 20% yield. Benzodioxepin 1.39 
was oxidised to the corresponding benzodioxepinone 1.40 in 59% yield. This was 
sUbjected to a stereoselective reduction using Corey's oxazaborolidine methodology.31 
This teclmology allowed both enantiomers to be developed. Ozonolysis of the 
resultant alcohols gave the desired alcohols, (R)- and (8)-1.41. Derivatisation with 
(R)-2-methoxy-2-phenyl-2-(trifluoromethyl)acetyl chloride (MTP A_Cl)32 and analysis 
using Mosher's method32 showed that the natural alcohol possessed the 8 
stereochemistry. 
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Figure 1.8 Key steps in Steglich and Anke's stereo-controlled synthesis of the 
benzodioxepin core of strobilurin 1. 
In this paper, Steglich and Anke also confinned the regiochemical arrangement of the 
gem-dimethyl groups present on the dioxepin ring. Nicholas et ai. had based their 
assignment of the methyl groups' position on an nOe correlation, but there had been 
some conjecture as to the accuracy of the assignment.26 The regioisomeric 
benzodioxepin1.42 was prepared and GC-MS comparison showed this to be different 
to rac-1.41 
~OxyCHO HO I ~ o 
1.42 
Although it was not discussed by the authors, it is clear that alcohol 1.39 could serve 
as an effective model system for a synthesis of 9-methoxystrobilurin K. If the methyl 
cinnamic ester was employed as the starting material, Wittig-based methodology 
similar to that employed in the synthesis of strobilurin E could potentially lead to the 
complete 9-methoxytriene system. 
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1.6 Synthetic strategy 
The syntheses in Section 1.4 demonstrate that while the strobilurin triene system can 
be generated, the methods employed to date are not entirely satisfactory. Clearly, 
there are stereochemical issues with the Wittig-based methodology and although the 
correct stereochemistry of the natural product is attainable via photoisomerisation of 
the all (E)-stereochemistry, it would be aesthetically more pleasing if a controlled 
route to the (E,Z,E) triene could be established. Additionally, there have been no 
syntheses of the 9-methoxy- or 13-hydroxystrobilurins. Thus, methodology which 
allowed the construction of either of these fragments would be desirable. The 9-
methoxystrobilurin sidechain poses the additional problem of the tetra-substituted 
double bond between carbons 9 and 10, this bears four unique substituents and as such 
presents considerable stereo- and regiochemical challenges in its construction. 
The synthetic strategy for the preparation of 9-methoxystrobilurin K can be divided 
into two main parts - the synthesis of the functionalised 1,5-benzodioxepin ring 
adjoined to the arene ring and the synthesis of the triene system. The key 
disconnections in the retrosynthetic analysis and the associated target fragments are 
shown in Figure 1.9. Literature precedent exists for the generation of benzodioxepin 
ring systems via a Lewis acid-catalysed attack of a phenol on an epoxide, in this case 
epoxide 1.42.33.34 After cyclisation, and with appropriate protection of the alcohol 
moiety present on the benzodioxepin ring, the aryl aldehyde moiety could be 
elaborated to the aryl alkyne (fragment 1.43) using the Corey-Fuchs homologation.35 
Methoxypropyne (1.44) can be prepared :fi:om commercially available 
chloroacetaldehyde dimethoxy acetal via elimination, to give the alkynyl anion. 
Methylation of this species "would then give methoxypropyne.36 Fragment l.4S 
(methyl-2-bromo-3-methoxypropenoate) has been prepared using a Stille coupling 
between methyl-E-2,3-dibromopropionate and tributytinmethoxide.37 
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Figure 1.9 Disconnection of 9-methoxystrobilurin K 
The strategy to be employed for coupling the fragments is shown below. It centres 
around carbostannylation of methoxypropyne with alkynyl stannane 1.47. Shirakawa 
et al. have shown that Pd-catalysed aryl alkyne carbostannylation with 
alkoxypropynes proceeds in high yield to give an alkene with the alkoxy unit and the 
tributyltin groups on different carbons.38 Thus, stannane 1.47 could be converted ether 
1.48. Reduction of the alkyne should give diene 1.49 and this could be coupled via a 
Stille-type coupling to methacrylate 1.45 to afford the protected version of 9-
methoxystrobilurin K (1.50). Stannane 1.47 should be readily generated from the 
alkyne 1.43 
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Scheme 1.5 - Coupling strategy to be employed for development of the 9-
methoxystrobilurin side chain. 
One of the strengths of this approach 'is that by changing the partner used for the 
carbostannylation the regiochemistry of the carbostannylation process can be 
reversed. Shirakawa et at showed that methyl propiolate underwent carbostannylation 
in the opposite direction to that of alkoxypropynes.38 An aryl alkynyl stannane should 
carbostannylate methyl propiolate to give an alkene with the ester moiety and the 
tributylstmmane on the same carbons. Applying this to alkynyl stannane 1.47, 
carbostalIDylation with methyl propiolate should give ester 1.51 (Figure 1.10). 
Reducing the ester to the alcohol and coupling with methacrylate 1.45 would afford 
the hydroxystrobilurin sidechain. This means that all known strobilurin side chains 
can be generated fOlm the same alkynyl stannane. Routes to the triene system are 
under investigation by another student in the Morris research group. 
1.47. 
+ Pd(O) 
.. 
H COzMe 
-~ .. _ hydroxystrobilurin D 
1.51 
Figure 1.10 - The key coupling step in the preparation of the hydroxystrobilurin 
sidechain 
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One of the major synthetic challenges posed by the strobilurin family is the 
preparation of the functionalised seven-membered benzodioxepin ring seen in 
strobilurins D, K and I. To the best of the author's knowledge there have only been 
two previous synthesis of this structural feature.30,33,34 Both of these have involved a 
Lewis acid-catalysed epoxide opening as the key step for fonning the dioxepin ring. 
The other two fragments required for this synthesis (1.43 and 1.44) can be prepared by 
literature methods. 36,37 However, alkyne 1.43 has not previously been prepared, and as 
such its synthesis offers the opportunity to test, and possibly extend, current synthetic 
methodology. This thesis deals with approaches to the construction of the 
benzodioxepin ring seen in some members of the strobilurin family. Coupled with 
this, is the chance to provide absolute confirmation of the proposed benzodioxepin 
structures of strobilurin D and hydroxystrobilurin D by achieving total syntheses of 
these matelials. 
Chapter Two 
Lewis Acid-Mediated Benzodioxepin Formation 
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2.1 Introduction 
Epoxides are a useful functionality for generating a wide range of oxygen-containing 
functionalities. Epoxides fragment when exposed to Lewis acids. Lewis acids lower 
electron-density on the oxygen atom and polarise the carbon-oxygen bond, making the 
carbon atom considerably more electrophilic. If the Lewis acid is strong enough, the 
carbon-oxygen bond can be polarised enough for it to cleave, thus giving a trigonal 
carbocation. Intramolecular nucleophilic attack by an oxygen atom on this pseudo~sp2 
centre can then result in the formation of an ether linkage. As discussed in Chapter 1 
literature precedent exists for constructing benzodioxepin ring systems via a 
regioselective Lewis acid-catalysed opening of an epoxide of the general type 2.4, in 
effect a 7~exotrig cyclisation.39 
ort ~OH 
Y 
R 
2.4 
Lewis 
acid 
.... 
OH 
ory qOH 
R 
2.5 
Figure 2.2 ~ Products of ionisation of epoxide 2.4 
or 
The Lewis acid can ionise the epoxide to give either the secondary, or tertiary 
carbo cation. Ionisation to the more stabilised tertiary carbocation and attack by the 
phenol would result in the desired benzodioxepin. 
2.2 - Paraherquamide B Studies 
The first reported use of a Lewis acid-catalysed epoxide rearrangement for forming a 
functionalised benzodioxepin was by Williams and co-workers in their development 
of a synthetic route towards the mycotoxic mould metabolite, Paraherquamide B 
(2.7),13,34 
Chapter 2 - Acid-mediated epoxide rearrangements 27 
2.7 
111is complex natural product contains a functionalised oxindole fused to a 
benzodioxepin system on its western side. This structural feature had not previously 
been synthesised. 
William decided to synthesise a precursor such as that shown below as it was 
reasoned that this compound could be easily converted to the desired alkene. 
A range of simple model systems were studied to determine the· most effective 
cyc1isation strategy.34 Attention was focussed on the key cyclisation reaction as it was 
expected that dehydration of the benzodioxepin would be relatively straight-forward. 
Two strategies were adopted for cyclising aryl alkene 2.8 as outlined in Figure 2.5. 
The first strategy involved a selenium-assisted carbocation formation. It was thought 
that the electrophilic selenium species would undergo addition to the alkene to yield 
the more stable teliiary carbocation, whereby intramolecular attack by the phenol 
would then give the benzodioxepin 2.11. However, when 2.8 was reacted with (N-
phenylseleno)phthalimide (N-PSP), the principal products arose from electrophilic 
aromatic substitution by the selenium species, with an overall yield of only 3% of the 
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desired selenobenzodioxepin 2.11. Due to this low yield, this method was abandoned. 
Interestingly, other substrates reacted in an efficient manner under these conditions. 
The alternative cyclisation strategy employed by Williams et al. involved a Lewis 
acid-catalysed epoxide rearrangement. Epoxide 2.9 was reacted with a stoichiometric 
amount of SnCl4 to give the desired seven-membered ring 2.10 in 59% yield, This 
clearly showed that benzodioxepins could be constructed by this type of methodology. 
o~ o~ 
&OH I ' d- ~OH V 
2.8 2.9, 
SePh 
o~ ~O 
V 
2.11 
OH 
o~ ~O 
V 
2.10 
O/\j-
~O 
l) 
Figure 2.3 - Williams et ai.' s cyclisation strategies towards a functionalised 
benzodioxepin. 
This work was repeated by Nicholas et al. to prepare the alcohol 2.10 so as to allow 
confirmation of their proposed structure of 9-methoxystrobilurin K (see Section 1.5). 
However, using the reported cyclisation conditions gave the benzodioxepin in less 
than 20% yield.41 Despite extensive repetition with careful attention to Williams et 
al. 's experimental conditions, the benzodioxepin 2.10 could only be obtained in 23% 
yield.16 
A range of other aryl systems were also studied to determine the effect of the 
substituents present on the arene upon the key cyclisation reaction. One model system 
that was investigated used the electron-poor arene o-nitrovanillin 2.12. This was 
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demethylated and alkylated using K2C03 and 4-bromo-3-methylbut-2-ene, ("prenyl 
bromide") as shown in Figure 2.4. The regiochemistry of the desired oxindole 
required alkylation at the 3-hydroxyl group. However, the 3-hydroxyl and 4-hydroxyl 
groups have very similar acidities. The electron-delocalising effects of the nitro group 
stabilise the 3-phenoxy ion, while the electron-delocalising effects of the aldehyde 
stabilise the 4-phenoxy ion. Thus, prenylation gave only a 20% yield of the desired 3-
alkyl product (2.14), with the principal by-products being the 4-alkyl and 3,4-dialkyl 
products. 
OH OH OH\ ¢COMe i) ¢CoH ¢Co .. I d- NO
z d- NOz 
92% d- N02 
20% 
CHO CHO CHO 
2.12 2.13 2.14 
Conditions - i) BBr 3, 
ii) prenyl bromide, K2C03, 
Figure 2.4 Williams et at. 's initial approach to a model system for cyclisation 
studies. 
Clearly, the substrate had to be altered so that there was a difference in the acidity of 
the two hydroxyl groups. Towards this end, the aldehyde was masked as the cyclic 
acetal 2.15, which removed the ability of the aldehyde to stabilise the 4-phenoxy ion, 
and hence, decreased the acidity of the 4-hydroxyl group. With this change, the 
selective prenylation of2.15 proceeded in 71 % yield to give alkene 2.16. 
Two approaches were attempted for the key cyclisation of alkene 2.16. The first 
involved a selenium-assisted cyc1isation using (N-phenylseleno )phthalimide and acid 
catalysis. This gave the selenide, which was eliminated using treatment with mCPBA 
and heating to give benzodioxepin 2.17 in 42% yield over two steps. 
7 
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The other approach involved a SnCl4-catalysed cyclisation like that used to construct 
the simple arene 2.10. Epoxidation of acetal 2.16 using mCPBA proceeded 
quantitatively. However, when the same conditions were applied to the deprotected 
aldehyde 2.14, two products were isolated; the teliiary alcohol dioxane 2.18 and an 
unidentified side-product. 
OH\ 
¢C:02 
CHO 
2.14 
i) 
O~H 
¢C:02 
CHO 
2.18 
+ 
Unidentified 
Product 
Conditions:- i) mCPBA 
Due to this side-reaction, the acetal-protected epoxide 2.19 was chosen as the 
cyclisation substrate. This was reacted with SnC14 to give the benzodioxepin 2.20 in 
modest yield (31%), which was deprotected (74%) and dehydrated (43%) to give the 
target benzodioxepin 2.21. 
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2.3 - Synthetic Strategy 
The target of the work discussed in this thesis is the alkynyl benzodioxepin 1.43. It is 
clear that dioxepins can be formed via Lewis acid-catalysed rearrangement of acyclic 
epoxides. To trial this strategy an epoxide such as 1.46 was required 
~orr# p l ~ o 
1.43 1.46 
Our strategy calls for the introduction of the allcyne after the formation of the 
dioxepin. As such, the R group present in epoxide 1.46 had to be stable to the 
cyclisation conditions and allow for the introduction of the allcyne after the 
cyclisation. 
The epoxide moiety in 1.46 can be prepared by epoxidation of the corresponding alkyl 
ether. One method for constructing aryl ethers is via the Williamson reaction of an 
alkyl halide with a phenoxide. In this case, the reaction of commercially available 4-
bromo-2-methylbut-2-ene with the appropriate aryl alkoxide should afford the aryl 
ether.30 The regiochemistry of the target strobilurin dictates that the 4-alkoxy species 
is the regioisomer required to form the desired benzodioxepin. 
Chapter 2 - Acid-mediated epoxide rearrangements 32 
Commercially available 3,4-dihydroxybenzaldehyde (2.22) neatly solves both of these 
problems. As previously discussed (see Section 1.6), the presence of the aryl aldehyde 
is satisfactory for later inb'oduction of the alkyne moiety using the Corey-Fuchs 
homologation.35 Additionally, the desired 4-alkoxy species should be selectively 
generated due to the 4-hydroxyl group being considerably more acidic than the 3-
hydroxyl group because of the electron-delocalising effects of the aldehyde. In this 
substrate, the 4-hydroxyl group has a pKa of 7.2, while the 3-hydroxyl is noticeably 
less acidic (pKn 11.8), so reaction with one equivalent of base would allow for 
selective alkylation. 
Based on this, the initial target for cyclisation studies was epoxide 2.24. The strategy 
employed for its synthesis is shown below. 
~ r4-OH 0 0 qOH Prenylation qOH Epoxidation qOH I~ )Iio I~ )Iio I~ 
CHO CHO CHO 
2.22 2.23 2.24 
2.4 Synthesis of an aryl aidehyde-fullctionalised epoxide as a 
substrate for cyclisation studies 
Synthesis of the aryl epoxide 2.24 began with the alkylation of commercially 
available 3,4-dihydroxybenzaldehyde, using the method of Dasenbrock and co-
workers.30 A solution of 3,4-dihydroxybenzaldehyde in DMF at OOC was treated with 
one equivalent of K2C03 and excess prenyl bromide. Stirring at room temperature for 
18 hours gave the desired alkene 2.23 in 74% yield. The IH nmr spectrum of this 
species was relatively simple as can be seen from Figure 2.15. 
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Figure 2.5 - 300MHz IH nmr spectrum of alkene 2.23 
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The triplet centred around 5.50 ppm corresponds to the alkenyl methine on the prenyl 
chain, while the doublet at 4.60 ppm corresponds to the prenyl methylene group. The 
two methyl moieties are present as two singlets at 1.80 and 1.75 ppm. 
Initial attempts at converting alleene 2.23 to epoxide 2.24 involved reaction of the 
alkene 2.23 with one equivalent of meta-chloroperbenzoic acid in CH2C12 at room 
temperature for 16 hourS.26,27 A significant change in the IH nmr spectrum ofthe crude 
reaction material was the disappearance of the aldehyde signal at 9.80 ppm of the 
starting material. In its place was a new singlet at 8.20 ppm which integrated for one 
proton.. This suggested that a formate ester such as 2.25 had been formed by a 
Baeyer-Villiger oxygen insertion into the arene-aldehyde bond.42 This is interesting in 
the light of Williams et al. observing a "mystery product" when attempting the 
buffered epoxidation of aryl aldehyde 2.14 using mCPBA.34 It seems plausible that 
tlus was a formate ester. In addition to the formate ester, a small amount of the desired 
epoxide was present. 
~ 
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Reasons for the preferential Baeyer-Villiger oxidation can be gleaned by looking at a 
mechanism for the Baeyer-Villiger rearrangement.42 Using benzaldehyde as a model, 
the mechanism is illustrated in Figure 2.6. It is thought that the first step in the 
reaction involves the ionisation of the carbonyl group to give a carbocation. This 
electrophilic centre undergoes peresterification with mCPBA. Migration of the phenyl 
group by nucleophilic attack on one of the peroxide oxygens, with concomitant loss of 
the free acid, gives a hemi-acetal. Loss of a proton yields the ester as the final product. 
It has been shown that the rate-determining step in the rearrangement is the migration 
step and this is concerted with peroxide cleavage.42 Given that both Baeyer-Villiger 
oxidation product 2.25 and epoxide 2.24 were formed, it would seem that the 
migration step and epoxidation occur at similar rates. 
OH 
Ph*H OH 
0 H'C(i p~l~' Ph)lH )IJo liI> 
:7"1 o ~;J 0 
:::::.... CI \..-H+ 
! 
0 OH 
Ph, )l ... Ph ~ 
o H '0 H 
Figure 2.6 - A proposed mechanism for the Baeyer-Villiger oxidation of 
benzaldehyde. 
The presence of the fonnate ester on the aryl ring was not satisfactory in terms oflater 
synthetic manipulation and so a method was sought to achieve preferential 
epoxidation over Baeyer-Villiger rearrangement. As the Baeyer-Villiger oxidation is 
believed to proceed via an ionic intermediate, while epoxidation is thought to proceed 
by a one-step non-ionic mechanism42 a less polar solvent should favour epoxidation, 
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since this Accordingly, epoxidation of 2.23 was attempted using mCPBA in benzene. 
This gave a mixture of formate ester 2.25 and the desired epoxide 2.24, suggesting 
that mCPBA was too strong a Baeyer-Villiger oxidant to allow for selective 
epoxidation. Clearly, a different epoxidising agent was required. The ability of a 
peracid to perform Baeyer-Villiger oxidation is directly rclated to the strength of its 
conjugate base. With a weaker base, both peroxide oxygens have increased electron 
density and hence are less electrophilic. Making the peroxide oxygen less electrophilic 
should make nucleophilic attack by the migrating species on the peroxy oxygen 
considerably slower. 
A review of the literature revealed that dimethyldioxirane is an effective epoxidising 
agent and a poor Baeyer-V illiger oxidant. 43,44 The chemoselectivity of 
dimethyldioxirane was illustrated by Curci et al. who reacted dimethyldioxirane with 
hex-I-en-S-one to give the epoxy ketone 2.26, without any Baeyer-Villiger oxidation 
occurring. 44 
o o 
~ ~ 
2.26 
Dimethyldioxirane is formed by the reaction between potassium peroxomonosulfate 
and acetone. This reaction proceeds via a Baeyer-Villiger-like mechanism. The first 
step involves nucleophilic attack by the potassium peroxomonosulfate on the carbonyl 
carbon. NUcleophilic attack by the carbonyl oxygen with subsequent loss of potassium 
hydrogen sulfate yields the cyclic peroxide.45 
Two methods exist for preparing dimethyldioxirane : 
e in sdu generation in a biphasic system,44 
e isolation in an acetone solution.46 
The in situ generation method has the advantage of being readily performed on a large 
scale. The difficulty with this method is the pH of the solution must be maintained 
between 7.S and 8.0 to ensure optimum alkene conversion.44 
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Initial studies using dimethyldioxirane used the in situ generation method. Alkene 
2.23 was reacted with acetone and Oxone® (potassium peroxomonosulfate) in a 
biphasic phosphate buffer/CH2Cl2 system held at O°C, using 18-crown-6 as a phase-
transfer catalyst.44 An Oxone® solution was added dropwise over one hour to the 
biphasic solution. After 4 hours, only starting materials were recovered. Despite the 
presence of the phosphate buffer, the reaction could not be maintained at a pH of 8. 
When the Oxone® solution was added the pH dropped to around 6.5. A 2 M solution 
of KOH was used to readjust the pH, but even adding these two solutions together still 
gave a significant pH drop. At acidic pH, any dimethyldioxirane which does form will 
be destroyed by acid-catalysed cleavage of the peroxide bond. Similarly, at pH greater 
than 8 potassium peroxomonosulfate dismutation is favoured.44 The authors note that 
a pH stat is used to control the pH during the addition of the oxone solution, however 
this type of device was unavailable and consequently, this method as abandoned. 
The alternative method for forming dimethyldioxirane involves its preparation as a 
O.IM solution in acetone.46 Around 100 mL quantities of this solution were routinely 
prepared using the method of Adam et al. .46 Solutions were stored in a freezer and due 
to the instability of dimethyldioxirane the solutions were used within a day. Reaction 
of alkene 2.23 with 1.5 equivalents of dimethyldioxirane for 2 hours gave the desired 
epoxide 2.24 in quantitative yield. The lH nmr spectrum of epoxide 2.24 is shown in 
Figure 2.7. The triplet at 5.50 ppm and the doublet at 4.60 ppm which were present in 
the IH nmr of the starting material had disappeared, indicating the loss of the double 
bond. The methylene protons were now split into two AB quartets centred around 
4.40 and 4.10 ppm, thus indicating that epoxidation had occurred and that the 
methylene group was now adjacent to a stereocentre. Additionally, the methine proton 
had shifted upfield to 3.20 ppm, indicating that it was in a different chemical 
environment. 
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Figure 2.7 - 300MHz IH nmr spectrum of epoxide 2.24 
Tin-(IV)-chloride mediated epoxide rearrangements 
With a viable route to the desired epoxide established, attention was turned to the 
Lewis acid-mediated cyclisation reaction. Based on William's work, initial cyclisation 
trials involved the reaction of epoxide 2.24 with the strong Lewis acid SnC14•47 The 
initial investigation repeated the exact conditions of Williams and co-workers, 
whereby one equivalent of freshly distilled SnCl4 was added dropwise to an ice-cold 
solution of epoxide 2.24 in THF. Although the intramolecular cyclisation would most 
probably be faster than any intermolecular reactions, the reaction solutions were 
relatively dilute (O.07M) to help minimise intermolecular reactions. The starting 
material was consumed after 45 minutes, but examination of the IH nmr spectrum 
indicated only small amounts of the desired benzodioxepin had formed. Reaction 
temperature and the order of substrate addition have both been shown to influence 
SnCl/s behaviour as a Lewis acid.48 Hence, the order of reagent addition, order of 
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substrate dissolution, and temperature were systematically varied as shown in Table 
Conditions Temperature Time 
SnCl4 added to epoxide solution ODC or 20°C or reflux 45 min 
Epoxide solution added to SnCl4 solution ODC or 20DC 45 min 
SnC14 solution added to epoxide solution ODC or 20°C 45 min 
Table 2.1 SnCl4-catalysed cyclisations 
These variations had little effect upon the cyclisation. The reactions performed at 
20De gave slightly higher levels of benzodioxepin 1.41 than those performed at O°C 
based on inspection of the lH nmr spectra. When the cyc1isation was performed in 
refiuxing THF, the reaction was substantially cleaner but the yield did not improve. 
This series of reactions demonstrate that the cyclisation conditions utilised by 
Williams et al. 33,34 were not effective for this substrate. 
The benzodioxepin 1.41 could not be separated from the isomeric dioxane 2.27 by 
chromatography using normal or reverse-phase silica. Presumably, dioxane 2.27 
forms when the epoxide ionises to give the secondary carbocation, with subsequent 
ring-closure giving 2.28. Oxidation of a mixture of 1.41 and 2.27 using pce gave the 
benzodioxepinone 2.28. This was now readily separated by chromatography, but the 
ketone 2.28 was only isolated in a disappointing 7% yield. 
Unless otherwise stated, all yields quoted in this section were determined using integration ofthe 
relevant peaks in the 'H nmr spectrum. Unless otherwise stated, all reactions involved one 
equivalent of the acid with one equivalent of epoxide 2.24 with the concentration at O.07M in 
epoxide. A summary of all the acid-catalysed cyc\isations can be found in Chapter 5 
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Extensive two-dimensional nmr studies allowed full IH and DC assignment of 
dioxepinone 2.28 as shown below. 
206.5 
4.85, 74.3~1'50'24.3 
153.6 g;O 0 .....-79.6 
6.96,114.9 I ~ ~ 134.5 
7.54,126./ ~ 7.54,125.1 
131.0 CHO 
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The major product from this series of reactions was identified as the six-membered 
ring hemiacetal 2.29, which lay in equilibrium with a small amount of the 
corresponding ring-opened ketone. 
O~ ~ 0 ~ OH ~ 0 
- ~OH I "'" I~ ~ 
CHO CHO 
2.29 
The 'H mnr spectrum of hemiacetal 2.29 is shown in Figure 2.8. The AB quartet 
centred around 4.20 and 4.00 ppm belongs to the methylene group and integrates for 
two protons. The splitting indicates the presence of the stereo centre on the adjacent 
carbon. The methine proton between the gem-dimethyl protons gives a distinctive 
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septuplet centred at 2.10 ppm. Although the hemiacetal is the major isomer, small 
amounts of the ring-opened ketone can also be seen. In this isomer the methylene 
group gives a singlet at 4.75 ppm, while the methine proton between the gem-
dimethyl protons gives a singlet at 2.70 ppm. 
10 9 a 1 6 5 4 3 2 ppm 
Figure 2.8 - 300MHz IH nmr spectrum of hemiacetal 2.29 
Figure 2.9 details a proposed mechanism for the formation of hemiacetal 2.29.49 The 
first step in this reaction would be the coordination of the SnCl4 to the epoxide 
oxygen. This oxycation could then eleave to give either a secondary or a tertiary 
carbo cation. Clearly, the tertiary carbocation 2.31 would be the thermodynamically 
more favourable product This was demonstrated by Williams et al forming the seven-
membered benzodioxepin, rather than the six-membered dioxane. This carbocation 
can then undergo one of two reactions; 
• nucleophilic attack by the phenol moiety to give the desired benzodioxepin 
.. a 1,2 hydride shift to give the secondary carbo cation 2.32. 
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Species 2.32 would only need to exist transiently as cleavage of the tin-oxygen bond 
would result in formation of the ketone isomer of hemiacetal 2.29. Isomerisation 
would then lead to the formation of the more stable six-membered ring hemiacetaL 
HO~CHO 
~/'oJV {O+ 
I 
CI-Sn 
/ \. 
CI C, 2.30 
2.29 
ionisation 
,.. 
lA-.,~ ~ H0yYCHO 
/+1"0~ 
Ck .... 0 Sn 
CI/ , 2.31 
CI 
t 1,2 Hydride shift 
H0yYCHO 
~~O~ C~,_ fa 
CI ..... S,n 2.32 
CI 
Figure 2.9 - A proposed mechanism accounting for the formation of hemiacetal 2.29 
Based on this mechanism, it would seem that epoxide 2.24 is ionising to give the 
desired tertiary carbocation, but the 1,2 hydride shift which results in the formation of 
hemiacetal 2.29, is favoured over the desired intramolecular nucleophilic attack by the 
phenol. Obviously, the fOl1nation of the benzodioxepin requires the alkyl chain to 
adopt a conformation which places the carbocation centre close enough to the phenol 
to allow for nucleophilic attack. Despite the arene ring removing one degree of 
freedom from any possible conformation, the nucleophile and the electrophile are still 
separated by five atoms. In contrast, the 1,2 hydride shift isn't dependant on 
conformation. Its only requirement is for the carbocation and the relevant hydrogen 
ato111 to be in the same plane. The exact product of the .cyclisation depends upon the 
relative fate of the alkyl chain attaining a conformation which allows for attack by the 
phenol, compared with the rate ofthe 1,2 hydride shift. 
Chapter 2 Acid-mediated epoxide rearrangements 42 
A mixtme of two other side products was observed in the III nmr spectrum. One of 
these compounds gave singlets at 5.15 and 5.00 ppm. The other compound, which was 
present in lesser quantities, gave signals at 6.00 and 5.85 ppm. This region is 
chaT3cteristic of olefinic protons, hence it was thought that these compounds were 
dehydration products. They could not be separated despite extensive chromatography. 
Given that these products were typically present in around 5% yield, their 
characterisation was not pmsued any further. 
2.6 - Investigation of other Lewis and Bronsted Acids 
The above work demonstrates that Williams et a1.'s cyclisation conditions do not 
provide a synthetically viable route to the desired benzodioxepin 1.41. It was decided 
to investigate the effects of using other Lewis acids upon the cyclisation in the hope 
that the yield of the desired benzodioxepin would be increased. 
Boron trifluoride diethyl etherate is known for its ability to mediate epoxide 
rearrangements.50Treatment of epoxide 2.24 with one equivalent ofBF3.0Et2 gave the 
hemi-acetal 2.29 as the major product, with a similar product distribution to that seen 
for the SnC14-catalysed cyclisations. Another strong Lewis acid, AICl3 gave an almost 
identical result. S I The similarity of the I II nmr spectra of these reactions to those of the 
SnCl4-catalysed cyclisations suggested that the use of these Lewis acids had very little 
effect upon the result of the cyclisation. This was in contrast to the reaction of TiCI/2 
with epoxide 2.24 which gave dioxane 2.27 as the major product, along with low 
levels of the hemiacetal 2.29 and benzodioxepin 1.41. Two equivalents of TiCl4 gave 
an identical result. This result is somewhat inexplicable as it suggests that TiCl4 
induces epoxide cleavage to give the secondary carbocation to afford the dioxane. 
However, given the low levels of benzodioxepin this reaction was not pursued any 
further. These results indicate that the use of a strong Lewis acid to initiate cyclisation 
still results in the preferential fOl1nation of hemiacetal 2.29. 
A range of other Lewis acids were trialed as cyclisation catalysts. LiCI04 is a mild 
Lewis acid, often used to catalyse epoxide rearrangement.S3 The reaction of one 
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equivalent of LiCI04 with epoxide 2.24 in diethyl ether took 48 hours for complete 
consumption of starting material. Unfortunately, the major product was still the 
hemiacetal 2.29. 
Cyclisation was attempted using trimethylsilyl trifluoromethanesulfonate (TMS-OTf) 
in THF, but again hemiacetal 2.29 was still the major product. Using DMSO as the 
solvent slowed this reaction greatly, with completion only being reached after 24 
hours, in contrast to the reaction in THF which took 30 minutes for complete 
consumption of starting material to occur. Disappointingly, hemiacetal 2.29 was the 
major product with only a low level of the benzodioxepin visible in the IH nmr 
spectrum. 
As previously discussed, (see Section 1.5) Steglich and co-workers prepared the 
benzodioxepin system 1.39 during their, confirmation of the absolute stereochemistry 
of strobilurin L30 This was formed by the lanthanum triflate-catalysed cyclisation of 
epoxide 1.38. When they trialed William's conditions involving SnCl4 in THF, they 
isolated the corresponding dioxane. Unfortunately, the use of Steglich's cyclisation 
conditions on epoxide 2.24 retu11led only starting material after 7 days 
HO~C02Et 
~/'O~ 
o 
i) 
... :t0~~ C02Et HO I o # 20% 
1.38 1.39 
Conditions - i) La(OTf)3, 7 days 
This series of experiments showed that variation in the nature of the Lewis acid did 
not significantly increase the benzodioxepin formed during the cyclisation. 
The next series of experiments involved investigations into the utility of Br6nsted 
acids as cyclisation agents. This was prompted by work on the synthesis of the 
diterpenoid oxepane Zoapatanol (2.33).54.55,56 
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The main structural feature of this potent contragestational species is the oxepane 
ring. Although a variety of strategies were adopted to develop the other functionality 
present in the molecule, all the syntheses completed to date have used acid-catalysed 
cyclisation of epoxide substrates to form the oxepane. 
For instance, in the key step of their synthesis of Zoapatanol, Chen and Rowand 
cyclised epoxide 2.34 to oxepane 2.35 using 10 mol% trifluoroacetic acid. 54 This 
reaction proceeded in a disappointing 30% yield, with the major product being the 
corresponding pyran .. 
OAe 
Me Me 
THPO OH 
o 
2.34 
i) 
30% 
Me 
THPO 
2.35 
Conditions - i) 10 0101% trifluoroacetic 
acid, 30 minutes 
OAe 
Initial investigations into the effects of Bronsted acid-catalysis involved the use of 
Nicolaou's method for oxepane synthesis. 57 Epoxide 2.24 was exposed to 10 mol % d-
camphor sulfonic acid in CH2CI2• This reaction was considerably slower than the 
equivalent Lewis acid reactions, with the starting material only being consumed after 
72 hours. The major product was identified as dioxane 2.27, with only very low levels 
of the benzodioxepin being present. 
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When a solution of epoxide 2.24 in CH2Cl2 was treated with 10 mol% trifluoroacetic 
acid in CH2CI2, only starting material was recovered after 90 minutes. This was 
interesting in the light of Chen and Rowand's oxepane cyclisation being complete in 
30 minutes. When the reaction was repeated using one equivalent of TF A the reaction 
was only 20% complete after 3 days. Eventually, it was found that the addition of 10 
equivalents of TF A and stirring for 24 h gave complete consumption of starting 
material. However, this gave a very complex IH nmr spectrum with only a 15% yield 
of the benzodioxepin. It is unclear exactly why these cyclisations were so much 
slower than the oxepane cyclisations discussed previously. 
Cyclisation using para-toluenesulfonic acid in CH2Cl2 was attempted. Whilst this 
reaction was considerably quicker than those involving the other Bronsted acids, it 
still gave only low levels ofbenzodioxepin 1.41. 
In summary, this series of experiments have shown that the SnCI/THF cyclisation 
conditions utilised by Williams for the construction of the non-functionalised 
benzodioxepin 2.10, is still the best method for the synthesis of 1.41 from epoxide 
2.24. However, this yield was less than 20% and as such, a Lewis or Bronsted acid-
mediated ring closure on substrate 2.24 is not a synthetically-viable route to the target 
benzodioxepin 1.41. 
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2.7 Investigation of an aryl bromide-functionalised cyclisation 
substrate 
46 
Based on Williams' success with functionalised substrates, it was thought that 
changing the functionality present on the arene may allow the benzodioxepin 
cyclisation to proceed in better yield. As previously discussed, any functionality 
introduced onto the arene ring must allow later introduction of an alkyne (See Section 
1.7), ideally in a single high-yielding reaction. 
{ Oif# PO I 
~ 
° 1.43 1.46 
It was thought that a bromine group in the 4-position would satisfy this requirement in 
that an alkyne could later be introduced using Sonogashira chemistry.58 Thus 4-
bromocatechol is the material required to begin this sequence. However, there is 
unlikely to be an intrinsic difference in the reactivity of the two hydroxyl groups as 
was seen in the 3,4-dihydroxybenzaldehyde system and therefore there would be no 
selectivity for the alkylation of the 4-hydroxyl group. As previously mentioned, this is 
required for the formation of the correct regioisomer of the target benzodioxepin. 
The observation of the propensity of aryl aldehydes to undergo Baeyer-Villiger 
oxidation lead us to the development of a synthesis that avoided these regioselectivity 
problems. The synthesis of the epoxide precursor is detailed in Figure 2.10. 
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Figure 2.10 - Strategy for the development of cyclisation substrate 
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The construction of epoxide started with the bromination of salicylaldehyde.59 A 
solution of one equivalent of bromine in CRCl3 was added dropwise to a solution of 
salicylaldehyde in CRCl3 at 30°e. The solution was refluxed for 2 hours to give the 
desired benzaldehyde 2.37 in 93% yield after dry column chromatography. Alkylation 
of 2.37 was carried out under identical conditions to those used previously.30 Reaction 
of phenol 2.37 with 1.1 equivalents of K ZC03 and prenyl bromide in DMF for 16 
hours gave the alkene 2.38 in 92% yield after flash chromatography. 
The next step in the preparation of 2.40 involved the one-pot epoxidation and Baeyer-
Villiger oxidation of alkene 2.38 to give formate ester 2.39. Initial studies involved 
the reaction of benzaldehyde 2.38 with 2.05 eq of mCPBA in CR2Cl2 for 2 hOllIS. This 
gave a 1: 1 mixtore of the desired epoxy formate ester 2.39 and the free phenol, with 
the 'R nmr spectrum of the two products being very similar. The principal difference 
was the proton on the formate ester moiety of 2.39, which was observed as a singlet at 
8.20 ppm. 
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An attempt was made to hydrolyse the mixture to the phenol by exposure to one 
equivalent of LiOH in a 1: 1 mixture of THF and methanol. 60 The solution was stirred 
for 30 minutes, to give a new product 2.41. The IH nmr spectrum of this product was 
significantly different from that of the starting mixture. Both the fonnate ester and 
epoxide signals had disappeared and had been replaced with an AB quartet at 4.40 
ppm and a multiplet between 3.85-4.00 ppm. 
:' 
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Figure 2.11 - 300 MHz 'H nmr spectrum of product 2.41. 
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The 'H nmr spectrum suggested that cyclisation had taken place to give either the 
target benzodioxepin (A), or the dioxane (B) 
OH OH ~H 
if o 4 2 I ~ 2¢:0 5 I~ 1 #6 1 #6 # 
Br Br 
A B 2.10 
An authentic sample of the non-functionalised bcnzodioxepin ring system 2.10 was 
available. Comparison of the lH mm spectrum for compound 2.41 with that of 2.10 
showed different chemical shifts to those of 2.10. Additionally, the new compound 
lacked a signal at around 3.80 ppm which corresponds to the methine in the non-
functionalised parent system. A variety of two-dimensional NMR experiments were 
pelfonned. HMBC analysis was inconclusive as the crucial correlation from C-6 to H-
4 in the dioxane structure was not observed. Given this ambiguity, it was decided to 
dehalogenate 2.41 and compare its data with those of benzodioxepin 2.10, thus 
offering more definitive proof of the compound's structure. 
Initial experiments involved the addition of a slight excess of freshly titrated n-BuLi 
to a solution of 2.41 in THF at _78°C. 60 It was thought that metal-halogen exchange 
would occur, with subsequent quenching with methanol resulting in the fonnation of 
the dehalogenated parent system 2.10. Disappointingly, tIus was not the case, with 
only starting material being isolated. A method developed by Corey and Suggs for 
dehalogenation using catalytic amounts of in situ-generated trialkyltin hydrides was 
next examined.6I However, the conditions reported gave only starting material 
contaminated with a tributyltin species. Given that these dehalogenations were 
unsuccessful, an attempt was made to form the para-nitrobenzoyl ester of 2.41. It was 
thought that tlus would make it more crystalline and additionally, the resultant ester 
would have an HMBC correlation which would allow confirmation of the proposed 
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structme. A solution of compound 2.41 was reacted with 1.1 equivalents of para-
nitrobcnzoyl chloride, 2.5 equivalents of triethylamine and a catalytic amount of 4-
dimethylaminopyridine (DMAP). However, even after 18 hours at room temperature 
only a mixtme of stm1ing material and para-nitrobenzoic acid was isolated. 
The identity of 2.41 was finally confirmed after extensive literature searching when a 
paper was found detailing the isolation and structural elucidation of Strobilurins F-2, 
G and H.62 Strobil min (2.45) was epoxidised using excess mCPBA and the 
resulting epoxide hydrolysed with Na2C03 • This gave dioxane 2.28, which was 
oxidised to the corresponding benzoic acid.62 
i), ii) 
.. 
2.28 
Conditions - i)mCPB1\ ii) saturated Na2C03. 
Comparison of the spectral data of both 2.28 and 2.41 led us to the assignment of 
structure B. The dioxane was presumably generated by deprotonation of the phenol, 
and subsequent attack by the phenoxide ion on the epoxide. To avoid this reaction, a 
method for generating the formate ester or the phenol cleanly was vitaL 
The reaction was repeated using one equivalent of mCPBA to investigate the relative 
rate ofBaeyer-ViIliger oxidation versus the rate of formate ester hydrolysis. This gave 
a complex mixture of both epoxidised and non-epoxidised ester 2.39 and alcohol 2.40. 
This indicated that the rates of epoxidation and Baeyer-Villiger insertion were 
comparable. The hydrolysis of formate ester was thought to be acid-catalysed and so 
attcmpts were made to buffer the epoxidation, such that the meta-chlorobenzoic acid 
(mCBA) fonned during the reaction was removed. This buffer had to be sufficiently 
basic to remove mCBA, but not so basic as to induce cyclisation to the dioxane. The 
mCPBA that was used in these reactions was purchased as a 70/30 mixture of 
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mCPBA/mCBA. This is significantly safer than pure mCPBA, which is both difficult 
to produce and shock -sensitive. Pure mCPBA can be obtained by stirring the mixture 
of acid and peracid in a pH=7,4 phosphate buffer.63 This separation method is based 
on mCBA being more acidic then mCPBA. Given that the epoxidation/Baeyer-
Villiger rearrangement results in the formation of mCBA, this would seem an 
adequate method for buffering the reaction. The reaction was attempted using 2.3 eq 
of bufIer to alleene 2.38, but phenol 2.40 was still observed in the 'H nmr spectrum. 
After extensive experimentation, it was found that the presence of a 0.1 M Na2H2P04 
solution gave the formate ester in good yield. Initial attempts at hydrolysis of the ester 
employed the method of van Reben.64 This procedure for the hydrolysis of aryl 
formate esters involves the reaction of twenty equivalents of potassium hydrogen 
carbonate with formate ester in a O.OIM solution of 2 parts methanol/I part water. 
Treatment of 2.39 for 20 minutes gave quantitative return of dioxane 2.43, thus 
indicating that these conditions are too vigorous to allow for the desired 
transformation. The reaction was repeated using 0.1 equivalents of potassium 
hydrogen carbonate. The major product was the desired phenol 2.40 with a small 
a11101111t of the dioxane 2.43. After a considerable amount of experimentation, it was 
discovered that refluxing the formate ester in methanol for 16 hours gave only the 
desired phenol 2.40.65 Sufficient quantities of phenol 2.40 were now available to trial 
the Lewis acid-catalysed cyclisations. Cyclisations were also attempted on the formate 
ester as it was thought that a Lewis acid might cleave the formate ester in situ and 
cyclise the resultant phenol in one process. 
Disappointingly, both of the aryl halide substrates gave poor yields of the target 
benzodioxepin in almost the same yields as those observed for cyclisation of aryl 
epoxide 2.24. The major product for all these reactions was hemiacetal 2.44, in 
equilibrium with its keto tautomer. Interestingly, cyclisations of formate ester gave 
approximately a 1:1 mixture of the hemiacetal to the ketone, as compared with a 95:5 
mixture for cyclisations of phenol 2.40. Once again, the target benzodioxepin could 
not be separated from dioxane 2.43 by flash chromatography and thus an accurate 
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yield could not be obtained. However, it was clear that the yields were comparable to 
those for the cyclisations in Section 2.5. 
O~ ~ O~H 0 cl OH ~ 0 - cloH cl° 1# ..... '# '# 
Br Sr Sr 
2.44 2.43 
While only a few Lewis acid catalysts were trialed for the cyclisation of epoxide 2.40, 
it was clear that from the previously observed behaviour of epoxide 2.24, the yield of 
the desired benzodioxepin would not increase significantly and as such, this was not a 
synthetically-viable route to the target benzodioxepin 2.42. 
2.8 Summary 
In summary, approaches towards a functionalised benzodioxepin ring system using a 
Lewis acid-mediated cyclisation were unsuccessfuL The fonnation of a six membered 
ring hemi -acetal occurred preferentially to the desired benzodioxepin cyclisation 
regardless of whether there is an aldehyde or bromide substituent present on the aryl 
ring system. TIns observation means this approach is not synthetically-viable for use 
in a total synthesis. 
Chapter Three 
PaUadiunl-Catalysed Aryl Ether Formation 
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3.1 Introduction 
Aryl ethers are a common structural motif found in a wide variety of 
pharmacologically-important natural products and drugs. These include compounds 
such as the opiate analgesic morphine (3.1), the anti-depressant Prozac® (3.2) and the 
antibiotic Vancomycin aglycone (3.3). 
N-Me 
F3C-Q-O Me ( NH 
H 
3.1 3.2 
0 OH 
N~~ 0 ~Me H N +NH 
0 H .:: 2 
.::::: 
OH r-HO 
3.3 
Figure 3.1 The aryl ether-containing pharmaceuticals morphine, Prozac® and 
Vancomycin aglycone 
Despite the structural simplicity of aryl ethers, their synthesis is often difficult. They 
are traditionally prepared by direct nucleophilic substitution by a hydroxyl group on a 
functionalised arene (referred to as SNAr-chemistry). Such a reaction involves the 
attack of an oxygen atom upon an electron-rich arene ring. The cloud of n-electrons 
which surround the arene ring make it a very poor electrophile. The presence of strong 
electron-withdrawing groups can increase the electrophilicity of the arene, thus 
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making attack more favourable. 66 Alternatively, the use of high temperatures and a 
highly polar solvent can allow this reaction to proceed. These conditions are intolerant 
to a wide range of functional groups, with the high temperatures and polar solvents 
facilitating a wide range of side reactions. As such, these couplings have limited use 
for intramolecular reactions.66 
The difficulties associated with preparing aryl ethers were recently exemplified during 
two total syntheses of the Vancomycin aglycone (3.3) by the groups of Evans67 and 
Nicolaou.os 
Vancomycin is a complex antibiotic used in the treatment of the highly-pathogenic 
bacterium methicillin-resistant Staphylococcus aureus (MRSA).69 Vancomycin is a 
heptapeptide containing three fused macrocyclic rings, each of which has associated 
atropisomerism due to the hindered rotqtion of each of the cyclic peptide subunits. 
This atropisomerism, in addition to the several unnatural amino acids present in the 
carbon skeleton, malces Vancomycin a challenging target for total synthesis. Although 
Vancomycin only contains biaryl ethers, some of the problems encountered its 
synthesis are illustrative of the difficulties in forming aryl ethers using traditional 
methodology. 
Vancomycin contains two biaryl ether linkages, centred around arene ring D as shown 
in Figure 3.1. This arene ring also lies at the head of two of the macrocyclic rings 
contained in Vancomycin. Construction of this structural motif was one of the 
wealmesses in Nicolaou synthesis.68 In this synthesis, the C-O-D ring macro cyclic 
system was the first to be constructed as the Ullman coupling conditions required 
would be too harsh for functionality which was to be introduced later in the synthesis. 
Nicolaou coupled the two arenes using chemistry that his group had previously 
developed.70 This involved the installation of a triazene functionality ortho to the 
coupling site. This acted as an "electron-sink" for nucleophilic attack on the aryl ring, 
thus allowing the coupling of substrate 3.4 to proceed in 60% yield, albeit as a 1: 1 
mixture of the desired and undesired atropoisomer, (see Figure 3.2) 
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Figure 3.2 Nicolaou et al. 's triazene-based cyclisation substrate. 
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In addition to the poor yield, another difficulty associated with this method of forming 
the aryl ethers in Vancomycin is the later requirement for the triazene to be converted 
to an alcohol. This was carried out late in the synthesis by a cumbersome series of 
reactions as shown in Figure 3.3. The triazene was reduced to the corresponding 
amine using Raney Nickel (85% yield), which was diazotised using HBF 4 and 
isoamylnitrite. The diazonium salt generated was reacted with Kl solution and the 
resultant iodide was converted to the corresponding boronate, which in turn was 
converted to the phenol using basic H20 2 , These transformations, combined with 
deprotection elsewhere in the molecule, occurred in 50% yield from the amine. This 
illustrates the principal wealmess of the triazene-based methodology. While the biary\ 
ether itself may form in acceptable yield, the triazene's later conversion to the 
required arene functionality often results in a considerable lengthening of the 
synthesis. 
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Reagents:- 1) Raney Ni (85%), 
2) HBF4 iso-amyl nitrite, then aqueous KI, 
3) B(OMeh, NaOHlH20 2 
Figure 3.3 - Nicolaou et al. 's alcohol formation strategy 
A milder method for constructing the requisite aryl ether would allow the preparation 
of an appropriate stereochemical template, upon which the C-O-D ring system could 
be constructed, thus affording better stereo selectivity. Additionally, if the cyclisation 
conditions are mild enough, more sensitive functionalities can be introduced prior to 
cyclisation. This sort of approach was seen in Evans' synthesis. Both biaryl ether ring 
systems were constructed via a Na2C03-catalysed SNAr reaction performed at room 
temperature, as illustrated in Figure 3.4. In this approach, the AB ring system was 
constructed first and the C-O-D macrocyc1e was later built onto this system. The 
substrate for these cyclisations was a fluoride-substituted aryl ring (C or E) to which 
phenol D was annealed. 
Conditions - Na2C03, DMSO, 1.5h 
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Figure 3.4 - Evans et aI's biaryl ether cyclisation substrate 
Cycl isation of this precursor occurred in 78% yield with a 5: I isomeric rati 0 in favour 
of the desired atropoisomer. This method employed relatively mild conditions and did 
110t have any effect on the sensitive functionalities and stereochemistry present 
elsewhere in the molecule. However, it has limited generality for preparing aryl ethers 
as the introduction of fluorine atoms onto arene rings via electrophilic aromatic 
substitution is difficult, due to such a reaction requiring the generation of a high 
energy cation. Indeed, in Evans et al. 's substrate, the fluorine atom was present in 
the commercially available starting materiaI4-fluorobenzaldehyde. 
Although the above discussion deals with the preparation of biaryl ethers, it 
exemplifies the difficulties associated with the preparation of aryl ethers. An 
alternative method which is available for forming aryl ethers by a Williamson-type 
etherification.7I Tllis requires the direct introduction of an alcohol on to the arene and 
subsequent reaction with the desired alkyl halide. One approach to such a 
transformation involves bromination of the arene and subsequent direct displacement 
of the bromide using -OR This typically requires activating groups on the arene 
and/or extremely high temperatures, which often result in low yields of the desired 
phenol. 72 An altemative method for the formation of aryl alcohols, shown in Figure 
3.5, starts with the conversion of the bromoarene to the corresponding aniline 
derivati ve. With activated arenes this can be achieved by direct treatment with either 
ammonia, a primary amine or a secondary amine. Contrastingly, non-activated arenes 
require treatment with the sodium salt of the desired amine. These reactions are more 
facile when using the primary or secondary amine. Once formed, the imine can be 
deprotected to give the free amine. The amine can be diazotised using nitrous acid. 
The diazonium salt which is formed is an excellent leaving group and thus allows for 
direct displacement using -OR When diazonium salts are made, they typically contain 
a small amount of water. Direct displacement by water is very slow at the 
temperatures employed for diazonium salt preparation (O-50C). However, if the 
reaction mixture is boiled, any excess nitrous acid is destroyed and nucleophilic 
substitution by water can occur on the arene. Altematively, the addition of Cu20 to a 
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dilute solution of the diazonium salt, with a large excess of CU(N03)2' allows the 
reaction to proceed at room temperature. 
Br OH 
6 6 
Figure 3.5 - Functional group interconversions leading to a free phenol from an aryl 
bromide. 
While this sort of procedure allows for the introduction of a hydroxyl group onto an 
arene, it is lengthy and often requires protection of functionalities present elsewhere in 
the molecule. Adopting such a strategy adds at least four steps to a synthetic sequence 
to achieve effectively only one functional group conversion. 
3.2 Pd-catalysed aryl ether formation 
It is clear that no general method exists for the direct introduction of a hydroxyl group 
onto an arene, or for forming aryl ethers by SNAr-type chemistry. The methodology 
discussed above can lead to their formation, but milder, general routes have not 
existed until recently. Methods for achieving these types of transformations were 
developed by the groups of Buchwald and Hartwig.77 Both groups had been seeking 
improved catalytic methods for forming aryl amines utilising the palladium-catalysed 
reaction of aryl halides with alkyl amines. Early work towards this end had involved 
the Pd-catalysed reaction of dialkyl tin amides with electron-neutral aryl halides. 73 
While this methodology provided good yields, it was substrate-specific. Additionally, 
difficulties in preparing air-sensitive tin amides and their considerable toxicity made 
this method far from ideal. 73 Guram and Buchwald improved upon this methodology 
by using tin ami des prepared in situ and this allowed a variety of aryl halides to be 
used. However, good yields (>80%) were only attained when using tin amides derived 
from secondary amines. In 1995, Hartwig75 and Buchwald76 concurrently published 
papers outlining methods for the tin-free amination of aryl halides. 'These reactions 
worked in both inter- and intra-molecular cases. 
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};'igure 3.6 - Buchwald's tin-free amination studies 
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An obvious extension of this amination work was to apply it to the formation of aryl 
ethers. Hartwig noted that reductive eliminations are faster with the more nucleophilic 
amines and thiolates. Given that alkoxides are less nucleophilic than either amines or 
thiolates,77 it was thought that the formation of aryl ethers by a Pd-mediated method 
would be difficult to accomplish. However, it was also noted that reductive 
eliminations from Pd were faster when the Pd was bound to electron-poor arenes. This 
suggested that if aryl etherification were to occur, it would be likely to display some 
degree of substrate specificity. In their seminal 1996 paper, Buchwald et al. 78 detailed 
the development of methods for Pd-catalysed intramolecular aryl ether formation. 
They showed that 3-5 mol % Pd(OAc)2 was capable of catalysing aryl ether formation 
under two sets of conditions:-
1) 511101 % Pd(OAc)2, 6 mol % Tol-BINAP (5), 1.2 equivalents ofK2C03 in toluene 
at 100°C. 
2) 3 mol % Pd(OAc)2' 3.6 mol % DPPF (6), 1.2 equivalents ofNaOtBu in toluene at 
80°C. 
Substrates reacted under the first set of conditions typically took around 24 hours for 
complete consumption of statiing material to occur. The second set of conditions 
resulted in more rapid substrate consumption (1-6 hours), but gave more side-
products. A variety of ligands were trial ed, with the chelating bis(phosphine) ligands 
Tol-BINAP (3.5) and diphenylphosphinoferrocene CDPPF 13.6) shown to be the most 
effective.78 
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Figure 3.7 The ligands used for Buchwald's Pd-catalysed, intramolecular aryl ether 
cyclisations. 
These conditions allow the cyclisation of five-, six- and seven-membered rings as 
illustrated in Figure 3.8 
HO Method 1. o:r ,.. CO< 89% # 0 Br 
OMOM 
Method 2. ,.. cQ OH 93% 
Br # 0 
~ Method 2. I # OH .. Br 64% 
Figure 3.8 - Examples of Buchwald et al. 's Pd-catalysed aryl ether cyclisations 
A number of functional groups were shown to be compatible with these cyclisation 
conditions, including acetals, silyl ethers and amides. The cyclisation conditions were 
found to favour te11iary alcohols. Reactions involving secondary alcohols required 
two equivalents of base relative to substrate and two equivalents of ligand relative to 
palladium in order to affect cyclisation. If this stoichiometry was lowered, secondary 
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alcohols were oxidised to the corresponding ketone. The mechanism for aryl ether 
formation by this method is thought to be analogous to that proposed for the Pd-
catalysed amination reaction (as shoVl.'n in }I'igure 3.9).79 Some validation of this 
putative mechanism was provided when intermediate 3.7 bearing a DPPF ligand was 
isolated and characterised.79 This complex was found to. be both chemically and 
kinetically competent as a catalyst for the formation of 2,2-dimethylchroman (3.8). 
~ ~oX 
3.8 
L Pd(O) 
n 
~OH I~ d- Br 
Base +HBr 
Base 
}I'igure 3.9 A proposed catalytic cycle for Pd-catalysed aryl ether formation. 
In a fm1her extension of this work, Hartwig and Mann developed methods for the Pd-
catalysed, intermolecular formation of aryl alcohols from aryl halides.so These 
methods centred around the reaction of the appropriate aryl halide with a 
Pd(OAc)/DPPF catalyst system, using NaOIBu as the oxygen source. The resultant 
aryl ether could be deprotected in situ using acid to yield the free phenol in one step 
from the aryl halide. This chemistry was limited to electron-poor arenes, with 
electron-neutral and electron-rich arenes not undergoing reaction. This work was later 
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extended by Hartwig and Mrum,8l who showed that a Ni(COD)/DPPF catalyst system 
provides improved yields as compared with the Pd(OAc)/DPPF system. 
3.3 Development of a substrate for Pd-catalysed aryl ether formation 
From the work discussed above, it is clear that aryl ethers can be formed via Pd-
catalysed intra-molecular ipso-attack of a hydroxyl group on an aryl halide.78 It was 
thought that these methods could be applied to the problem of benzodioxepin 
formation, potentially allowing access to this frunily of oxygen heterocycles, and thus 
the desired members ofthe Strobilurin family. This would offer an opportunity to test, 
and possibly extend, the Pd-catalysed aryl ether formations discussed above. Aryl 
dioxepin 3.9 can be discol111ected at either of the two arene-oxygen bonds. However, 
in light of Buchwald's observations that these type of cyclisations are more favourable 
with tertiary alcohol substrates, the obviQUS discolli1~ction a 
R 
3.10 
Figure 3.10 - The key discolli1ection for dioxepin cyclisation via Pd-catalysed aryl 
ether formation. 
Therefore, the synthesis of alcohol 3.10 needed to be developed to allow investigation 
of these cyclisations. A plan for its preparation is detailed in Figure 3.11. 
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Figure 3.11 - General synthetic scheme for the development of aryl dioxepin 
cyclisation substrate. 
It was envisaged that commercially-available 4-hydroxybenzaldehyde would be an 
appropriate staliing material as the strong activating effects of the hydroxyl 
functionality would allow the introduction of a halogen at the 3-position with respect 
to the aldehyde. Literature methods exist for introducing a bromide82 or an iodide83 
into this position. Both bromides and iodides have been shown to be amenable to 
Buchwald's cyclisation conditions.78 The appropriate four carbon chain should be 
readily introduced by alkylation of the hydroxyl group to give the prenyl ether 3.13. 
This could be achieved by utilising similar chemistry to that employed in the 
syntheses of the epoxide substrates discussed in Chapter 2. This alkene can be 
elaborated to give diol 3.14 by the use of standard dihydroxylation methods. This 
would generate a substrate with the required oxygenation pattern. Diol 3.14 could 
potentially be cyclised using Buchwald's conditions, in that it has the requisite 
halogen and tertiary alcohol groups. However, it was anticipated that the secondary 
alcohol may require protection as in 3.15, so as to prevent its oxidation to the ketone. 
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Initial studies towards the preparation of alcohol 3.15 involved the selective 
bromination ofthe 3-position of 4-hydroxybenzaldehyde to give aryl bromide 3.16.82 
OH ¢ 
CHO 
3.11 
i) 
OH Ar-Br y 
CHO 
3.16 
Conditions i) Br2' CHCl3 
This was carried out via the addition of a bromine solution in CHCl3 to a solution of 
4-hydroxybenzaldehyde in CHCI) at 40°C. Heating for one hour gave the desired 3-
bromo-4-hydroxybenzaldehyde in 85% yield after flash chromatography. The 
pmification of the crude reaction product was readily achievable by flash 
chromatography on a scale of around one gram. However, on larger scale reactions, 
the reaction product was not sufficiently soluble to allow effective chromatography. 
Due to this problem, when large scale reactions were conducted the mono bromide-
dibromide mixture was directly converted to the corresponding prenyl ethers. The 
alkyl derivatives were substantially more soluble and were easily separated by flash 
chromatography. 
Another obvious choice for a cyclisation substrate would be an iodo-functionalised 
phenol such as 3.12 (X=I). This is because palladium-species undergo oxidative 
addition to a carbon-iodide bond more readily than to the analogous carbon-bromide 
bond.84 Buchwald et al. found that aryl bromides were suitable substrates for the aryl 
etherification. 7S Only one example of an aryl iodide was used in their study and 
interestingly, this gave a lower yield than the corresponding aryl bromide (see Figure 
3.12). Additionally, the cyclisation of the iodinated-substrate was substantially slower 
than the corresponding bromide. 
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Figure 3.12 - Buchwald et al.'s investigation of the effects of changing aryl halides 
on cyclisations. 
Accordingly, it was decided to focus on the use of the bromo-functionalised substrate 
3.16. The fonnation of prenyl ether 3.17 involved the same alkylation chemistry as 
utilised previously (see Chapter 2).30 Monobromide 3.16 was alkylated under standard 
conditions using a slight excess of prenyl bromide and K2C03 in DMF to give the 
desired alleene 3.17 in 93% yield. The ~plitting pattern in the lH nmr spectrum was 
analogous to that observed for 3-hydroxy-4-(2-methyl-but-2-en-l-yloxy)benzaldehyde 
(see Chapter 2). The chemical shifts of this were also almost identical to those 
recorded for that material. 
OH Arsr y 
CHO 
3.16 
O~ Arsr y 
CHO 
3.17 
Conditions i) K2C03, prenyl bromide 
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Figure 3.13. - The 300MHz lH nmr spectrum of alkene 3.17 
The next step in the preparation of substrate 3.15 was the dihydroxylation of alkene 
3.17 to form diol 3.18. Alkyl diols can be prepared from the conesponding alkenes 
via the use of stoichiometric amounts of osmium tetroxide. However, osmium 
tetroxide is both expensive and highly toxiC.85 A method employing only catalytic 
amounts of osmium tetroxide (1 mol %) was developed by Van Rheenen et at. using 
N-methylmorpholine-N-oxide (NMO) as the stoichiometric co-oxidant. 85 The 
reactions are carried out in a mixed solvent system of 25 parts water, 10 parts acetone 
and 2 pmis tert-butanol. This solution is the key part of the catalytic method, in that it 
allows all three reagents to be dissolved in a relatively homogeneous solution. While 
the actual oxidations are slow, typically overnight, they are generally free of side 
products and result in high yields of the diol. 
O~ Ar-sr y 
CHO 
3.17 
OH 
~ Q-0~ Sr OH I . ....9 
CHO 
3.18 
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The method for working up these dihydroxylation reactions involves the reduction of 
the osmate species present in solution to osmium metal via the addition of sodium 
sulfite. The osmium metal can then be safely removed by adsorption on magnesium 
si licate. 85 
Using the dihydroxylation conditions of Van Rheenan et at. gave the desired diol as a 
gum. This required azeotroping with hexane and ether to remove the remaining 
solvent, to give diol 3.18 as a brown solid in 87% yield, which was used without 
further purification. 
10 8 7 6 5 4 3 ppm 
Figure 3.14 - 300MHz IH nmr spectrum of dio13.18 
As can be seen in Figure 3.14, three new sets of signals have been generated in the IH 
nmI' spectrum, centred around 4.30 ppm, 4.20 ppm and 3.80 ppm. respectively The 
two higher field signals correspond to the methylene present on the alkyl chain. They 
are present as an AB quartet, with a considerable amount of associated fine-structure, 
indicating their coupling is not-first order. Presumably, the fine structure is a result of 
the newly-created stereocentre which is now present on the adjacent carbon. The 
multiplet at 3.80 ppm obviously corresponds to the methine which is now a 
stereocentre. Unsurprisingly, given the absence of the olefmic system, the methyl 
protons had also shifted upfield substantially and were now centred around 1.30 ppm, 
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as compared with being around 1.80 ppm in the starting alkene. Reaction yields were 
consistent as the reaction scale was increased, with the reaction being successfully 
performed on five grams of alkene 3.17 With this route established, sufficient material 
was available to trial the Pd-catalysed cyclisations. 
3.4 Cyclisation Trials 
The crucial aryl halide and tertiary alcohol moieties required for arene coupling are 
present in diol 3.18. The only dilemma remaining was the presence of the secondary 
alcohol should it be protected? Buchwald et al. noted that secondary alcohols are 
oxidised under their Pd-catalysed cyclisation conditions unless an excess of both base 
and catalyst was used. However, none of the substrates investigated by Buchwald et 
a1. contained both a tertiary alcohol and a secondary alcohoL From Buchwald's results 
it was felt that it might be possible that the tertiary alcohol would cyclise 
preferentially to the secondary alcohol oxidising. 
When the cyclisation was attempted on diol 3.18 using Pd(OAc)2/Tol-BINAPI K2C03 
at 100°C for 48 h, a mixture of starting material and a less polar compound was 
isolated. This new compound was identified as ketone 3.19 upon inspection of the 
comparatively simple lH rum spectrum shown in Figure 3.15. The aromatic protons 
did not change significantly. The alkyl methylene gave a singlet at 5.20 ppm and the 
two methyl groups a singlet at 1.50 ppm. 
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Figure 3.15 - 'H rum spectrum of the ketone 3.19. 
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CHO 
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i) Pd(OAc)z, K2C03, Tol-BINAP, 
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Figure 3.16 - Attempted cyclisation of dio13.18 using Buchwald's conditions 
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Clearly, the secondary alcohol was oxidised in preference to the cyclisation and 
because of this, the secondary alcohol would require some form of protection before 
cyclisation coultl take place. 
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The principal requirement of such a protecting group was stability to basic conditions. 
The presence of either K)C01 or NaOtBu was shown to be an essential requirement for 
the Pd-catalysed aryl ether cyclisations78 and as such, the protecting group had to be 
stable to these conditions. 
Accordingly, benzyl and silyl ether protecting groups were the first to be investigated. 
It was expected that selective protection of the secondary alcohol would be less 
sterically-hindered than the tertiary alcohol with its associated gem-dimethyl groups. 
Benzyl ethers are generally formed via the reaction of a benzyl halide with the 
appropriate alkoxy anion, while their cleavage is achieved using hydrogenation on a 
metal catalyst. 87 
Treatment of a solution of diol 3.18 in THF at 0 °C with one equivalent of sodium 
hydride, followed by the addition of one equivalent of benzyl bromide gave a 
complicated mixture of products. Flash chromatography allowed the isolation of the 
two regioisomeric benzyl ethers 3.20 and 3.21. The lH nmr spectra of 3.20 and 3.21 
are shown in Figures 3.17 and 3.18 respectively 
( 
10 8 5 3 2 ppm 
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Figure 3.18 300 MHz IH mnr of secondary-protected benzyl ether 3.20 
( 
10 9 B 7 6 5 4 3 ppm 
Figure 3.17 - 300 MHz lH nmr of tertiary-protected benzyl ether 3.21 
Compound 3.20 was identified as the desired secondary-protected alcohol by the 
appearance of an AB quartet centred around 5.10 and 4.75 ppm in the IH nmr 
spectrum. This was attributed to the benzyl methylene group being close to a 
stereo centre. Contrastingly, the benzyl group in 3.21 gave only a singlet at 4.55 ppm. 
Full IH and 1JC nmr assignments were achieved by two-dimensional nnn' experiments 
as shown in Figure 3.19. The regioisomeric connectivity of the benzyl ether products 
was confirmed by HMBC con-elation experiments. The crucial con-elations which 
allowed the confirmation of the regioisomerism of the ethers are shown in Figure 
3.19. The key correlation in the secondary ether was from the diastereotopic benzyl 
methylene group across the ether bond to the methine stereocentre. In the case of the 
tertiary ether structure, this would be an unlikely four bond con-elation. Compound 
3.21 gave a three bond correlation from the quaternary carbon attached to the gem-
dimethyl groups across to the benzyl methylene, thus confirming that it was the 
tertiary ether. 
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Figure 3.19 - IH and BC data for benzyl ethers 3.20 and 3.21 based on 
HMBC/HSQC-experiments. (All data are in the form oH/le.) 
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Figure 3.20 - The key HMBC correlations which allowed determination of the 
regiochemistry of the benzyl products 
Although the initial benzylation allowed full identification of both 3.20 and 3.21, they 
were isolated in low yield (9% and 5% respectively). Despite much experimentation, 
the yield of the desired ether 3.20 could not be increased. 
The most commonly used silyl protecting group is the tert-butyldimethylsilyl 
(TBDMS) group.87 Mild methods for its introduction were developed by Corey and 
Venkateswarlu.88 These involve the use of TBDMSCI, with imidazole as the base and 
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DMF as the solvent. Previous methodologies for formation of TBDMS ethers had 
involved the use of excess chlorosilane and excess dry pyridine at elevated 
temperatures. 89 In addition to developing these mild formation methods, Corey and 
Venkateswarlu showed that silyl ethers could be readily cleaved to give the fi'ee 
alcohol by using excess tetra-N-butylammonium fluoride (TBAF).88 Alternatively, 
TBDMS ethers may be cleaved using mild acid treatment (2:1 acetic acid/water at 25 
DC). Buchwald et al. showed that TBDMS ether linkages were stable to the Pd-
catalysed cyclisation conditions employed and thus, the synthesis of TBDMS ethers 
of diol 3.18 was investigated. 
The secondary alcohol in 3.18 was also protected as the tert-butyldimethyl silyl ether. 
The standard conditions for this protection involve reacting the substrate alcohol with 
excess TBDMSCI and imidazole in a concentrated DMF solution.88 When this was 
attempted on diol 3.18, no reaction was observed after 24 hours. 4-
dimethylaminopyridine (DMAP) has been shown to increase the rate of TBDMS ether 
formation reactions.90 The silylation was attempted using 1.5 equivalents of 
imidazole, 0.2 equivalents of DMAP and one equivalent of TBDMSCI in a DMF 
solution. After the suspension was stirred for 36 hours the sHyl ether 3.22 was 
obtained in 38% yield after flash chromatography. The remainder of the mixture was 
starting material, which would seem to indicate that the reaction occurs slowly, 
presumably because the bulky TBDMS group is slow to react with the hindered 
alcohol moiety. 
CHO 
3.22 
Figure 3.21 - The desired TBDMS ether 
I 
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Two sets of changes were observable in the IH runr spectrum of tertiary alcohol 3.22 
relative to that of the starting material; the appearance of signals corresponding to the 
methyl and tert-butyl groups of the TBDMS moiety and the multiplet of the methine 
stereocentre shifting downfield 0.10 ppm. While it was assumed that the desired 
secondary ether had been fonned, this could not be confirmed by runr methods as any 
useful C-H bond correlations would be over four bonds, including one Si-O bond. 
This is beyond the scope of a normal HMBC experiment. A solution to this problem 
was found via the use of single-crystal x-ray crystallography. Happily, this confirmed 
that 3.22 was the desired secondary protected silyl ether. 
An attempted silylation using the more reactive tert-butyldimethylsilyl triflate gave a 
complex mixture of silylated and non-silylated products. Although the silylation using 
TBDMSCI was far from ideal, enough material was available to trial Buchwald's 
cyclisation conditions using this substrate. 
i Protecting group Conditions Yield of desired 
material 
Benzyl leq BnBr, 1 eq. KOtBu, THF, 25°C, 9% 
16 hours. 
Tert-butyl 1.2 eq. TBDMSCI, 1.5 eq. Imidazole, 38% 
dimethyl sHyl DMF, 25°C, 36 hours. 
(TBDMS) 
Table 3.1 - PreparatlOn of the benzyl and TBDMS-protected cychsatlOn substrates. 
With the two tertiary aryl alcohols readily available by the above routes, it was 
possible to trial Buchwald et al.'s cyclisation conditions. These cyclisations were 
attempted on the same scale as that employed by Buchwald et al., namely 0.3 mmol. 
Given that the bases involved were highly sensitive to small amounts of water, 
particularly sodium tert-butoxide, all manipulations were performed in a glove box. 
Disappointingly, even with extended heating, neither of the substrates gave any 
reaction upon exposure to either set of Buchwald et al.'s cyclisation conditions.78 
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The principal difference between the substrates and those successfully employed by 
Buchwald is the presence of the adjacent benzyl or silyl ether. While none of 
Buchwald's substrates were aryl aldehydes, it has been shown that these type of 
cyclisations occur more rapidly with electron-poor arenes.77 However, both benzyl and 
TBDMS groups provide substantial steric bulk near the tertiary alcohol. Given the 
size of these groups, it seemed plausible that their steric bulk is in some way slowing 
the palladium-catalysed reaction 
Since the benzyl and TBDMS ethers failed to cyclise, it was decided to trial a less 
sterically demanding protecting group. If it was the steric bulk of the benzyl and 
TBDMS groups that was preventing reaction, a smaller protecting group should allow 
the cyclisation to proceed. It was decided to protect the hydroxyl group as the 
methoxymethyl acetal (MOM). This was one of the protecting groups shown to be 
stable to Buchwald et al. 's cyclisation conditions. Like most acetals, MOM-protected 
alcohols are stable to base, an obvious requirement for any protecting group used in 
this synthesis (vide inji'a). One drawback of the use of MOM ethers is the 
comparatively harsh conditions required for their deprotection, which usually involves 
strong Lewis or Bronsted acid-catalysed cleavage. The earlier work on acid-catalysed 
epoxide opening showed that the target dioxepin ring was stable to a range of Lewis 
and Bronsted acids, so the MOM group should be removed after cyclisation. 
Initial studies investigating the protection of the dio13.18 as the MOM ether involved 
the reaction of a solution of diol 3.18 in CH2Cl2 with 1.1 equivalents of 
methoxymethyl chloride (MOMCI) and 1.4 equivalents of Hunig's base. These 
conditions resulted in incomplete reaction after 24 hours. The addition of an extra 0.5 
equivalents of MOMCI and 0.6 equivalents of Hunig's base, and a further 12 hours of 
reaction allowed complete consumption of starting material and the generation of two 
products. Clu'omatography of the reaction mixture allowed separation of the two 
products to give the desired secondary-protected alcohol 3.23 in 38% yield and the 
regioisomeric alcohol 3.24 in 30% yield. The IH nmr spectra of these two products 
were very similar to those encountered with the conesponding benzyl ethers. Alcohol 
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3.23 gave an AD quartet centred at 5.00 and 4.80 ppm, which were assigned to the 
diastereotopic methylene of the MOM group. The only other addition to the spectrum 
was a singlet at 3.50 ppm, which corresponds to the methoxy ether present in the 
MOM group. Contrastingly, the lH rum spectrum of 3.24 gave two new singlets, one 
at 4.80 ppm assigned to the methylene of the MOM group and the other at 3.40 ppm 
assigned to the methoxy group. The regioisomerism of the alkylation was determined 
based on these splitting patterns. 
CHO 
3.23 
OH 
~ OMe 
¢r0'" Br 0-.1 1,,9 
CHO 
3.24 
Figure 3.22 ~ The two MOM ethers isolated from the MOM-protection trials 
Although once again the yield of 3.23 was far from ideal, sufficient material was 
available to trial the cyclisation reactions. The first cyclisation method to be trialed 
involved the K2CO/Pd(OAc)/Tol-DINAP system, but heating alcohol 3.23 with this 
catalyst system for 48 hours gave no reaction. However, use of the 
NaOtBu/Pd(OAc)/DPPF system did give some reaction. The catalyst system was 
removed by filtering the reaction mixture through a silica plug. This method was not 
ideal for working up this particular reaction as material was lost, presumably due to 
adsorption onto silica. Even with extensive washing with methanol, mass balance was 
not attained. However, the product mixture showed the presence of two main 
products. One was identified as the dehalogenated arene 3.25 (14%). The IH nmr 
spectrum of the product gave only two signals in the aromatic region, a doublet at 
7.80 ppm and a doublet at 7.00 ppm, both of which integrated for two protons. 
Electron Impact Mass Spectroscopy (ElMS) confirmed that the material had been 
dehalogenated. This suggested that the Pd catalyst had undergone oxidative addition 
to the aryl-bromide bond, but the reaction had not proceeded further. Hydrolysis of 
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the Pd-Br species either in situ or during workup would then allow for the formation 
of 3.25. The other product of the reaction could not be purified and accordingly, was 
not conclusively identified. Again, its IH Imlr spectrum gave two doublets in the 
aromatic region, at 7.90 ppm and 6.95 ppm. However, the main change was the 
disappearance of the aldehyde signal, which had been at 9.90 ppm in the starting 
material. It was thought that the aldehyde may have been oxidised to give a carboxylic 
acid. The increased polarity of the compound relative to 3.25 and 3.23 concurred with 
this proposal. 
OMOM OMOM 
O~H O~H ¢ ¢ 
CHO COOH 
3.25 3.26 
Figure 3.23 - Two of the products of the MOM-protected ether cyc1isations. 
The removal of the bromide in these two products was a reassuring result, in that it 
confilmed that the Pd-catalyst can undergo oxidative addition to the arene-bromide 
bond. This indicated that the presence of the aldehyde on the arene did not impede the 
oxidative addition. However, the reaction did not proceed further. It was assumed that 
the tertiary alcohol was not chelating to the Pd-catalyst and thus, cyclisation could not 
occur. 
At this point, the protection strategy for the secondary hydroxyl group was re-
evaluated. It was clear that even a relatively small protecting group such as a MOM 
ether prevented the key cyclisation from occurring. However, the secondary hydroxyl 
group must be included as it is part of the natural product. When it was exposed to the 
cyclisation conditions, it was oxidised to the corresponding ketone. These results 
provoked the thought that the conversion of the hydroxyl group to the ketone as in 
3.19 might be a way to reduce the steric bulk adjacent to the tertiary alcohol. 
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Figure 3.24 - Keto-protected cyclisation substrate 3.19 
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The catalytic tetrapropylammonium perruthenate (TP AP) system developed by Ley 
and co-workers was investigated for the conversion of diol 3.18 to ketone 3.19,93 
Catalytic TP AP oxidations are normally carried out in CH2Cl2 and require 5 mol% 
TPAP, with NMO as the stoichiometric co-oxidant. The great strength of the TPAP 
methodology is its requirement for only a catalytic amount of the oxidant, as 
conipared with other mild oxidation protocols such as the Dess-Martin periodinane,94 
or the Swern oxidation,95 TPAP also avoids the harsh conditions and difficult work-up 
associated with chromium-based oxidants such as pyridinumchlorochromate (PCC),96 
Ley's standard method for oxidation involved 0.05 equivalents of TPAP being added 
to a suspension of 1.5 equivalents of NMO, diol 3.18 and powdered molecular sieves 
in CH2Cl]. Stirring for two hours and filtering through a silica plug eluting with ethyl 
acetate gave a mixture of approximately 75% starting diol and 25% of the desired 
ketone 3.19. When the reaction was repeated and left to stir for 12 hours, only 30 % 
conversion was obtained. It has been found that some TP AP oxidations fail to go to 
completion when performed in CH2C12 •93 The addition of 10% acetonitrile is reported· 
improve this conversion rate. 93 It is thought that acetonitrile has this effect by 
increasing the number of TP AP turnovers. The acetonitrile has to be removed before 
filtering through silica as it can co-elute residual TPAP.93 When this method was 
trial ed, an improved but still disappointing 40% yield was obtained after two hours at 
room temperature. As a method of last resort the reaction was attempted using 
acetonitrile as the solvent. This also gave a 40% yield of the desired ketone. It has 
been shown that TP AP displays some sensitivity to steric hindrance around a target 
hydroxyl group and that this is particularly a problem with sterically-congested 
secondary alcohols. 93 Given the slow speed of the TBDMS ether formation and the 
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resistance to complete conversion to TPAP oxidation, it would seem plausible that the 
secondary alcohol exists in a relatively hindered conformation, thus denying these 
regents ready access to the hydroxyl group. At this point two options were available; 
either find a more effective oxidising agent, or use TP AP and accept a 40% 
conversion. It was decided to continue using TP AP as it allowed for relatively quick 
reactions, easy separation, and the stru1ing material could be easily recovered. It was 
found that the yields for this oxidation stayed constant with larger scale reactions, thus 
allowing access to sufficient material to trial the cyclisation. 
When the cyclisation of ketone 3.19 was attempted using the NaOtBuJDPPFlPd(OAc)2 
system, destmction of the substrate resulted after heating for 8 h. Mass balance was 
not attained, even with extensive washing of the silica plug. The reaction mixture was 
only slightly soluble in CHC13, with only aromatic protons being visible in the IH 
spectmm. Although the exact reason for substrate destmction was not elucidated, a 
potential explanation can be seen in the stmcture of ketone 3.19. The alkyl chain has a 
methylene group on the carbon a to the ketone. Obviously, these protons have a 
relatively high acidity due to the ketone's ability to delocalise a negative charge at this 
position by fOITllation of the corresponding enolate. Thus, upon exposure to the strong 
base N aOtBu, deprotonation to give 3.30 could occur competitively with the 
cyc1isation. In aqueous solution the t-butoxide anion has a pKb of 16 whereas the 
protons on a carbon a to a carbonyl have a pKa of around 20, suggesting that the 
deprotonation would not occur. However, changing the solvent to toluene is likely to 
have a significant effect upon these values. 
o 
IBucr R V Ho OH ~Br y 
CHO 
3.19 
O· 
A 
AI 0 ,,:0 _H_---4II .... Y .. Polymerisation 
CHO 
Figure 3.25 A potential mechanism for destmction of ketone 3.19 when exposed to 
the N aOtBu/DPPF IPd(OAc )z-based cyclisation conditions 
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If deprotonation were to take place, the resulting carbanion could undergo 
intermolecular aldol reactions with the aldehyde, to afford polymeric material. 
When ketone 3.19 was exposed to the altemative K2CO/Tol-BINAPlPd(OAc)2 
cyclisation conditions, it gave a most interesting result. Heating for 24 hours afforded 
a mixture of two products in the ratio of 5.5:1. Chromatography of the mixture 
allowed their separation. The minor product of this reaction (7% yield) was found to 
be the dioxepinone 2.29. The data for this compound were found to be identical to 
those recorded previously (see Section 2.5). Although this was an very low yield, the 
result was met with a degree of jubilation as it proved that functionalised 
benzodioxepin rings could be constructed by a Pd-mediated aryl ether forming 
reaction. 
The major product was isolated in 39% yield and had a IH nmr spectrum that was 
initially surprising. Little change was observed in the aromatic protons. However, the 
methylene signal at 5.20 ppm had disappeared and an AB-type system had developed 
at 4.30 and 4.10 ppm, similar to that seen in the secondary alcohol and secondary 
ether substrates (vide infra). This seemed to indicate that a stereocentre had been 
fonned in the molecule. Additionally, a singlet which integrated for three protons was 
seen at 2.40 ppm. Extensive two-dimensional rum experiments lead to the conclusion 
that the product was a-ketol 3.28.97 
0 OH 
A 00° ~Br OH ,.. qBr I§ I§ 
CHO CHO 
3.19 3.28 
Figure 3.26 - Ketol 3.28, the major product of the Pd-catalysed cyclisation attempts 
on ketone 3.19. Conditions i) 0.05 eq Pd(OAc)2, 0.06 eq Tol-BINAP, 1.2 eq K2C03, 
Toluene, lOO"C, 24 hours. 
Chapter 3 - Palladium-Catalysed Aryl Ether Formation 
1.48,21.4 ~78.0 4.28,4.13174.~~~ 210 
159.0 Q; 2.42,25.0 
Br 
7.01,112.7 ~ ......... 131.0 
7.83,131.9 I # 8.05,134.5 
CHO 
9.83,189.4 
3.28 
81 
Figure 3.27 - 'H/'3C-based nmr assignments for a-ketoI3.28 based on HMBC/HSQC 
experiments (All data are in the form 0H'OC') 
Presumably, this compound results from a methyl group shifting in a 1,2 fashion to 
give the observed a-ketol. It is reported that base is required to catalyse this 
rearrangement, presumably by deprotonating the alcohol. 
~OH OH 00° oC/'-qBr ~Br 1# ... 1# 
CHO CHO 
3.19 3.28 
However, it seemed unlikely that a base as weak as K2C03 could affect deprotonation 
of the hydroxy group in ketone 3.19. Thus, it was postulated that the Pd species may 
be acting as a catalyst for the reaction. By chelating the two oxygen atoms, it could 
aid methyl transfer by evenly distributing any charge-buildup during the reaction. To 
test this hypothesis, the reaction was repeated in the absence of both Pd(OAc)2 and the 
Tol-BINAP ligand. Heating with potassium carbonate at 100°C for 22 hours in 
toluene returned only ketone 3.19. This offers some validity to the proposal that the a-
ketol rearrangement is catalysed by the Pd-species present under the cyclisation 
conditions. TIns is an encouraging result in that it suggests that by altering the nature 
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of the Pd species which is present in situ, the a-ketol rearrangement might be 
suppressed and thus, allow for the dioxepin to form preferentially. 
3.5 Summary 
A low-yielding synthesis of dioxepinone 2.29 by a Pd-catalysed aryl ether formation 
has been described. Investigations of this Pd-catalysed reaction have indicated that the 
presence of the bulky benzyl and TBDMS protecting groups prevent the key 
cyclisation reaction from occurring. It has been shown that aryl bromides are capable 
substrates for the oxidative addition of a Pd species under these conditions. 
The smaller MOM protecting group allows the initial Pd oxidative addition into the 
arene-bromide bond to occur, but the reaction does not proceed further. 
Converting the hydroxyl group into the ketone allows the cyclisation to occur, albeit 
in 7% yield. Unf0l1unately, this substrate preferentially undergoes a rearrangement to 
give an a-ketoL It would appear that this rearrangement is Pd-mediated. A clearer 
understanding of the mechanism of this reaction will require further investigation 
before the yield of the dioxepinone 2.29 can be increased. 
Chapter Four 
Summary and Future Potential of these Studies 
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4.1 Summary and Future Potential of these Studies 
The two synthetic approaches discussed in this thesis have resulted in two low-
yielding syntheses of the benzodioxepin ring system found in members of the 
strobilurin family. The yield of the Lewis acid-catalysed epoxide opening, previously 
used by Williams ef al.,33.34 Nicholas et al. 26,27 and Hellwig et aZ. 30 to form the 
benzodioxepin system, displays a considerable degree of substrate dependence. As 
such, its use to construct the benzodioxepin core of 9-methoxystrobilurin K as part of 
a total synthesis is not viable. 
r-4-o 
~OH 
R 
Lewis 
acid 
.. I~ 
~ 
R 
OH 
The Pd-mediated aryl ether formation offers more hope for the development of an 
efficient synthesis of the target benzodioxepin system. These cyclisations display 
sensitivity to steric bulk adjacent to the nucleophile tertiary hydroxyl group and as 
such, the use of the large benzyl and TBDMS protecting groups prevent the reaction 
from occurring. The use of the smaller MOM protecting group allows the Pd species 
to undergo oxidative addition to the arene-bromide bond, however the reaction does 
not proceed further. The keto-protected substrate undergoes cyclisation, but an a-keto I 
rearrangement occurs preferentially. This rearrangement appears to be Pd-assisted and 
as such, varying the nature of the ligands chelated to the Pd may allow for the 
selection ofthe cyclisation reaction over the a-ketol rearrangement. 
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Near the end of the work discussed in this thesis, an account was published of the 
development of an extremely active Pd catalyst system for fonning tert-butyl ethers 
from aryl halides.98 It was found that a mixture of 2 mol % Pd(OAc)2 and 6 mol % 
PCBu)} allowed the formation of tert-butyl ethers when reacted with a range of aryl 
halides and 1.2 equivalents of NaUBu. In an interesting extension to the work of 
Buchwald discussed in Chapter 3,78 this reductive elimination occurred with both 
electron-rich and electron-poor arenes. This catalyst system would seem to offer a 
alternative to Buchwald's Tol-BINAP- and DPPF-based systems. The use of a less 
crowded phosphine to chelate the Pd could alleviate the problems encountered with 
the more bulky DPPF and Tol-BINAP ligands. 
Hartwig and Mann's work on the use of Ni(COD)iDPPF as a catalyst for the 
formation of protected phenols81 also offers some hope for forming the target 
benzodioxepin by an approach involving reductive elimination. Although this method 
and the Pd(OAc)/PtBu catalyst system were developed for forming protected phenols, 
their use could be potentially be extended to allow intramolecular cyclisations. These 
catalyst systems offer additional hope for affecting the benzodioxepin cyclisation, 
rather than the a-ketol rearrangement. The unavailability of these catalysts prevented 
the investigation of their use during the course of the work discussed in this thesis. 
An alternative strategy for preparing the benzodioxepin species draws on the work of 
Bravo et aes who investigated the relative rates of formatiim of a variety of medium-
sized rings by acid-catalysed epoxide rearrangement, such as that detailed in Scheme 
4.1 by a favoured 7-exo-trig cyclisation. Treatment of olefin 4.2 with mCPBA gave 
the corresponding benxooxepin in 70% yield. 
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Scheme 4.1 Bravo's epoxide reanangement approach to the formation of 
benzooxepins. 
To trial such an approach, an olefin such as 4.4 would be required. This could be 
prepared by reaction of 3,4-dihydroxybenzaldehyde with bromo acetal 4.3 as shown .. 
Deprotection of the acetal and reaction with 2-propenyl lithium should give 4.4. It 
would be hoped that he allylic alcohol and the phenol will have differing reactivity, 
allowing selective protection of the allylic alcohoL Epoxidation of the alkene, 
followed by cyclisation should afford the hydroxymethyl dioxepin. Deoxygenation of 
the resultant alcohol should afford the desired benzodioxepin. 
I~ H0X)CHO ~O HO~CHO o~~ 
i) deprotection 
:(
0yYCHO 
~ 
HO Base o 
HO ~0X)CHO deoxygenation zoX)CHO PO I .... PO I ~ ~ o 0 
... 
HO )VJ 
o 
4.4 
i) protection I 
ii) epoxidation. 
:to HO cyclisation X)CHO .... I PO ~ o 
Obviously such an approach would still be open to undesired epoxide rearrangements 
such as those discussed in Chapter 2. 
An alternative strategy for the cyclisation of olefin 4.4, would be to use an 
oxymercuration approach.loo Electrophilic addition of mercuric acetate or mercuric 
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trifluoroacetate to olefin 4.4 should result in the formation of the mercurate 4.5 based 
on the addition occurring to give the more stable tertiary carbocation, with subsequent 
attack by the phenol resulting in benzodioxepin ring formation. 
:=(0yYCHO HO ~ o 
4.4 
oxymercuration 
... 
(ACO)ZH9 O)()CHO 
HO I 
# 
o 
4.5 
Reduction of mercurate 4.5 with sodium borohydride should replace the mercurate 
group with a proton, while the aldehyde would also be reduce, it can be oxidised 
selectively using Mn02 as detailed by Steglich 30 to afford the desired benzodioxepin. 
Chapter Five 
Experimental 
Chapter 5 Experimental 
5.1 General Methods 
Spectroscopic Considerations 
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Proton-detected NMR spectra were obtained on either a Varian Unity 300 
spectrophotometer or a Varian XL300 spectrophotometer, both operating at 300 MHz. 
Carbon-detected NMR spectra were obtained on an XL300 spectrophotometer 
operating at 75 MHz. All spectra were obtained at 23°C. The reverse-detected HSQC 
and HMBC experiments were obtained on the Unity 300 spectrophotometer operating 
at 300 MHz. At various stages this instrument was fitted with a Pulsed Field Gradient 
MLD driver with a 5mm Indirect Detection Probe. Chemical shifts in this thesis are 
recorded in parts per million (ppm) on the a scale. All NMR spectra were recorded in 
CDCl1, referenced to CHCl3 at OH 7.26 and Oc 77.01. 13C nmr spectra were typically 
obtained with a delay (DJ of Is. HMQC experiments were run with a D\ of LOs and 
iJCH = 140 Hz. HMBC experiments were run with a D1 of 0.3 s, \JCH = 140 Hz and 2JCH 
8.3 Hz. 
Mass Spectrometry was performed on a Kratos MS80 Mass Spectrometer operating at 
4kV. 
IR spectra were obtained using a Shimadzu 8201PC Series FTIR interfaced to an Intel 
486 PC rulming Shimadzu's HyperIR software. Spectra were run either neat on a KBr 
disk, or in CIICI} solution. 
Reagents, Solvents and Experimental Considerations 
All reactions were performed in either oven- or flame-dried glassware under a 
nitrogen or argon atmosphere. Analytical thin-layer chromatography (TLC) was 
conducted on aluminium-backed Merck Kieselgel KG60F254 silica plates. 
Visualisation was by short-wave ultraviolet light and subsequent staining with either 
anisaldehyde, IOv1n04, or 2,4-dinitrophenylhydrazine solutions. Flash 
chromatography was performed on Merck Silica 60 follow the guidelines of Still and 
co-workers. 102 Solvents were purified by well-established procedures. Io3 
Tetrahydrofuran and diethyl ether were distilled from sodium benzophenone ketyl 
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immediately prior to use. Toluene and CR2Cl2 were distilled from CaR2 prior to use. 
N.N-Dimethylfonnamide (DMF) was dried by standing over freshly-activated 4 A 
molecular sieves for two periods of 24 hours, before finally being stored under AI 
over fresh 4 A molecular sieves. This was degassed under high vacuum for 2 minutes 
immediately prior to use. 
Unless otherwise stated, all organic fractions were dried over Na2S04 and filtered 
before solvent evaporation in vacuo. 
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Experiments described in Chapter 2 
3-Hydroxy-4-( 3-metbyl-but-2-en-l-yloxy)benzaldebyde 2.25 
OH O~ 
c70H 1,-7 .. c70H 1,-7 
CHO CHO 
2.22 2.23 
3,4-Dihydroxybenzaldehyde 2.22 (1.025 g, 7.42 mmol) was dissolved in DMF (37 
mL) and cooled to one, After 10 minK2C03 (1.026 g, 7.42 mmol) was added via 
solid addition tube with vigorous stirring. 4-Bromo-2-methyl-buten-2-ene (940 ilL, 
8.16 mmol) was added dropwise over five min and the solution left to warm to RT. 
After 18 hours the reaction was quenched by the addition of 1M HCl solution (25 mL) 
and the resultant solution extracted with ethyl acetate (3 x 50 mL). The combined 
organic phases were washed with H20 (2 x 100 mL) and brine (1 x 100 mL). The 
solvent was removed in vacuo to yield the crude product as a brown solid (1.560 g). 
Flash chromatography on silica using 25% ethyl acetate - petroleum ether as eluant, 
gave the title compound 2.25 as pale yellow crystals (1.126 g, 74%). 
1 II NAJR (CDCl)) 0 9.83 (s, IH, ArCHO), 7.39 - 7.43 (m, 2H, ArH), 6.94 - 6.97 (d, 
J HH 8.3 Hz, 1 H, ArH), 4.67 (t, JHH = 6.8Hz, HI, CH2CHC(CH3)2)' 1.80 (s, 3H, 
CH2CHC(CH3)2), 1.76 (s, 3H, CH2CHC(CH3)2)' 
13e NA1R (CDCI3) 0 191.05,151.21, 146.32, 139.76, 130.34, 124.42, 118.27, 114.00, 
111.17,65.88 ,25.69, 18.18 . 
HREIMS calc. for C12 H140 3: 206.0943; found 206.0940. 
FTIR (cm- I , CHCl3) 2855, 1668. 
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m.p. 68-69°C (recrystallised from ethyl acetate - hexane to give lemon plates). 
Preparation of Dimethyldioxirane solution 46 
A 3L, three-necked flask was fitted with a solid-addition funnel, a mechanical stirrer 
and a distillation tube. To the other end of the distillation tube was fitted a 250mL 
two-necked collection flask cOImected to a vacuum source. The 3L reaction flask was 
charged with acetone (144 mL, 1.96 mmol), distilled water (190.5 g, 10.58 mol) and 
sodium bicarbonate (43.5 g, 0.52 mol). The resulting white suspension was stirred 
vigourously for 5 min and the reaction flask cooled to 4 DC via an ice-bath. The 
collection flask was cooled to -78 DC using an acetone/dry-ice bath. Oxone® (90 g, 
0.146 m111ol) was added in one portion to the stirred sodium bicarbonate suspension 
and. the solid-addition funnel was replaced with a thermometer. After 15 min of 
vigourous stirring, a vacuum was applied (70-90 mmHg) and the reaction flask was 
warmed to 30 DC via a warm water bath. The reaction flask was maintained at 30 DC 
for 90 min at which time the vaCUlun was removed and the system flushed with argon. 
The pungent yellow solution in the collection flask was dried, filtered with activated 4 
fA sieves (5 g) and decanted into a flask containing fresh 4 fA sieves. The flask was 
flushed with argon and kept at -18°C. Immediately prior to use the dimethyldioxirane 
was titrated by the method of Adam et al.46 
3-Hydroxy-4-(2,3-epoxy-3-methylbut-2-en-l-yloxy)-benzaldehyde 2.24 46 
O~ O~ 
~OH qOHO 1# .. 1# 
CHO CHO 
2.23 2.24 
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The alkene 2.25 (800 mg, 3.88 mmol), was cooled to -30 DC using a liquid N/ 
bromo benzene slush bath. A solution of dimethyldioxirane in acetone (0.092M, 63.5 
mL, 5.83 mmol) was added via pipette under a rapid flow of argon. The golden yellow 
solution was allowed to warm to DC over 20 h and the acetone was removed in 
vacuo. The resulting yellow emulsion was diluted with ethyl acetate (50 mL) and this 
solution was washed with brine (1 x 50 mL). The solvent was removed in vacuo to 
give the title compound 2.24 as a golden gum (864 mg, 100%). 
iH NMR (CDCl}) 59.84 (s, 1H, ArCHO), 9.45 - 9.39 (m, 2H, ArR), 7.00 (d, J HH = 
8.4Hz, 1H, ArH), 4.39 (dd, ~m 7.4, 3.9 
6.3, 4.4 Hz, IH, OCH2HCOC(CH3)2) 
OCH2HCOC(CH3)2)' 1.41 (s, 3H, 
OCH2HCOC(CH3)2)' 
IH, OCHlICOC(CH3)2)' 4.13 (dd, JHH 
3.17 (dd, J HH 3.9 Hz, 2.4 Hz 1H, 
OCH2HCOC(CH3)2)' 1.38 (s, 3H, 
13C Nl\!JR (CDCI)) 191 151.1, 146.4, 130.9, 124.4, 114.7, 111.6, 68.4, 60.9, 58.7, 
24.5, 19.0. 
HREIMS Calc. for C12H140 4 : 222.0892; found: 222.0901. 
SnC14-mediated cyclisation of epoxide 2.24 
O~ OH O~ qOHO Q-0 .. 1# + 1# 
CHO CHO CHO 
2.24 1.41 2.29 
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Tin (IV) chloride (76 I-lL, 0.65 mmol) was added dropwise to a golden-yellow 
solution of epoxide 2.24 (145 mg, 0.65 mmol) in THF (9.3 mL). The reaction was 
stirred for 30 min and quenched by the addition of aqueous saturated sodium 
bicarbonate solution (50 mL). The cloudy solution was extracted with ether (3 x 
50mL). The combined organic phases were washed with water (2 x 50mL) and brine 
(1 x 50ml). The solvent was removed in vacuo to give the crude product (183 mg). 
Pmification by flash chromatography on silica using 30 % ethyl acetate - petroleum 
ether as the eluant, gave:-
(i)Hemi-aceta12.29 (65 mg, 45%) 
IH NMR (CDC13)8 9.81 (s, 1H, ArCHO), 7.45-7.40 (m, 2B, ArH), 7.04 (d, JHH 8.8 
Hz, 1H, ArH), 4.25 (d, J = 11.3 Hz, 1H, OCH2HCOC(CH3)2), 3.98 (d, JHH 11.3 Hz, 
IH, ArOCH2), 3.25 (br s, IH, OB), 2.10 (sept, JHH 6.8Hz, 1H, H3CCHCH3), 1.13 (d, 
.II Iii == 6.8Hz, 3H, CHlICCH3), 1.09 (d, J Illf 7.3 Hz, 3H, CH3HCCH3). 
13C NA;fR (CDC1,) 8 190.9, 148.2, 142.0, 131.0, 124.4, 123.7,118.7, 117.3, 116.3, 
113.8,96.1,67.9,34.4, 16.4, 15.5. 
HREJA1S Calc. for C12H1404: 222.0892 ; found: 222.0892. 
Selected 'H nmI' data on the ring-opened ketone form 
1 H M\4R (CDC13) 89.83 (s, 1H, ArCHO), 6.87 (d, J = 7.8 Hz, IH, ArH), 4.83 (s, 1H, 
ArOCH2CO), 2.73 (sept, 1H, H3CCHCH3). 
(ii) A mixture of more polar products was also isolated (38 mg) and this contained the 
desired benzodioxepin and the six-membered ring tertiary alcohol. This mixture was 
subj ected to PCC oxidation as described by Steglich30 to allow separation. 
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4 ,4-dim ethyl-3-oxo-3,4-d ihydro-2If-benzo-[b ]-[1,4] -dioxepin-7 -carbaldehyde 2.29 
OH 0 
o~ o~ 
c70 qo I~ )to I~ 
CHO CHO 
1.41 2.29 
To a stirred suspension ofPCC (44 mg, 0.22 mmol) in CH2Clz (0.35 mL), was added 
a solution of the above mixture (30 mg, 0.14 mmol) in CH2Cl2 (0.57 mL). After 24 h, 
the black suspension was washed with ether (3 x 5 mL). The yellow washings were 
concentrated and purified by flash chromatography on silica using 25% ethyl acetate -
petroleum ether as the eluant, to give the benzodioxepin 2.29 (9 mg, 7% over two 
steps). 
1 H Nl'1R (CDCl,) 0 9.87 (s, IH, ArCBO), 7.54 (m, 2H, ArB), 7.06 (d, JHH = 8.8 Hz, 
IH, ArB), 4.85 (s, 2H, ArOCB2), 1.50 (s, 6H, COC(CH3)z' 
13e N]yJR (CDCI,) 0 206.5, 189.6, 153.6, 134.5, 126.5, 125.1, 114.9, 79.6, 74.2, 
24.3. 
HREIAfS Calc. for C I2H120 4: 220.0736 ; found: 220.0732. 
FTIR (em-I, CHC13) 1693, 1604.7. 
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3-Formyl-4-[(2-hydroxy-2-mcthyl)]-cthyl)-2H-l,S-bcnzodioxane2.28 60 
O~ o0H qOH qo 1# .. 1# 
CHO CHO 
2.24 2.28 
LiOH (6.2 mg , 0.299 mmol ) was added via a solid addition tube to a solution of 
epoxide 2.24 (53 mg , 0.239 mmol) in methanol (0.65 mL) and THF (0.65 mL). The 
resulting green solution was stirred for 30 min and quenched by acidification of the 
solution using 5% HCI aqueous solution. The solution was diluted with water (20 mL) 
and extracted using CH2C12 (3 x 40 mL). The organic extracts were washed with water 
(2 x 100 mL) and brine (1 x 75 mL). Removal of the solvent gave the title compound 
2.28 as a brown gum (53 mg, 100%) 
iH(CDCl]) 0 9.81 (s, 1H, ArCHO), 7.39-7.45 (m, 2H, Adl), 6.99(d, JHH 8.3 Hz, 
lH, ArH) , 4.51(dd, JHH 9.7Hz, 2.0Hz, IH, ArOCH2), 3.91-4.09 (m,lH, 
l3e NA1R (CDC13) 0190.7,148.8,143.9,130.5,124.4, 118.l, 117.4,78.6,70.5,65 
.7, 8,25.3. 
HREIMS Calc. for C12H J40 4: 222.0892; found 222.0897. 
FTIR (em-I, KBr disk) 3440.8, 1585.8. 
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2-Hydroxy-5-bromo-benzaldehyde 2.37 59 
OH 
~CHO 
l) 
2.36 
OH 
~CHO 
Y 
Br 
2.37 
95 
A solution of 2-hydroxybenzaldehyde (1.743 g, 14.3 nunol) in CHCl3 (2.30 mL) was 
heated to 30°C and a solution of Br2 (740 ilL, 14.3 mmol) in CHCl3 (2.30 mL) was 
added dropwise over 20 min. The solution was heated at reflux for 2 h and upon 
cooling to RT gave a cream solid (2.750 g). Purification using dry column 
chromatography with 25% ethyl acetate - petroleum ether as eluant gave the title 
compound 2.38 as a cream solid (2.67 g, 93%). 
1 H NMR (CDC1,) 8 10.93 (s, IH, ArOH), 9.84 (s, 1H, ArCHO), 7.67 (d, J HH 2.4 
Hz, IH, ArH), 7.60 (dd,J}IH 6.3,2.5 Hz, 1 H, ArH) 6.91 (d,J}lH 8.8 Hz, ArH). 
13C NMR (CDC1,) 8195.35, 160.46, 139.62,35.56,121.66,119.74, 111.29. 
m.p. 103-104°C (recrystallised from ethyl acetatelhexanes to give stout white rods), 
lit. melting point = 105°C 
2-( 3-Methyl-but-2-en-l-yloxy)-5-bromobenzaldehyde 2.38 
OH O~ 
<r
CHO 
I§ .. <r
CHO 
I§ 
Br Br 
2.37 2.38 
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K}CO] (1.114 g, 8.43 mmol) was added to a solution of 2-hydroxy-5-
bromobenzaldehyde 2.38 (1.538 g, 7.66 mmol), in dry degassed DMF (26.4 mL). The 
resulting bright green suspension was stirred for 15 min. 4-Bromo-2-methyl-but-2-ene 
(970 ~lL, 8.43 mmol) was added over 10 seconds and the resulting yellow suspension 
was stirred for 15 hours. 1M HCI (25 mL) was added and the resulting solution was 
extracted with ethyl acetate (3 x 25 mL). The combined organic phases were washed 
successively with water (2 x 100 mL) and brine (1 x 100 mL). Removal of the solvent 
in vacuo gave the crude product as a yellow oil (2.070 g), which solidified upon 
standing. This was purified by flash chromatography, using 5% ethyl acetate -
petroleum ether as the eluant, to give the title compound 2.39 as a yellow oil (1.895 g, 
92%). 
I H NMR (CDCl,) (5 10.35 (s, 1H ArCHO), 7.85 (d, lHH 2.9 Hz, IH, ArH), 7.55 (dd, 
lHH = 6.4 Hz, 2.4 Hz, 1H, ArH), 6.86 (d, .fyrn 9.3 Hz, HI, ArH), 5.41-5.46 (m, 1H, 
CH2CHC(CH,)2)' 4.58 (d, lHH 6.3 Hz, 2H, CH2CHC(CH])2)' 1.77 (d, lHH 1.0 Hz, 
3H, CH2CHC(CH3)2), 1.72 (s, 3H, CH2CHC(CH3)2) 
13C NAiR (CDCl3) 8 188.5, 160.1, 139.2, 138.1, 130.8, 126.3, 118.5, 115.0, 113.3, 
65.8,25.76,18.31, 
HREIMS calc. for C12HI30 2Br: 268.0099; found: 268.0095. 
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Preparation of 3-Bromo-4-( (2-hydroxy-2-methyl)-ethyl)-2H -1,5-benzodioxane 
2.44 
o~ ~H o . qOH qo 1# 1# 
Br Br 
2.38 2.41 
Alkene 2.39 (200 mg, 0.744 mmol ) in CH2C12 (1.1 mL) was added via cannula to a 
solution of mCPBA (404 mg, 1.64 mmol) in CH]C12 (2.6 mL) at 0 DC (ice bath). The 
solution was warmed to RT and after 16 h, quenched by the addition of the white 
suspension to an ice-cold saturated aqueous NaHC03 solution (30 mL). The organic 
layer was removed and the aqueous phase extracted with CH2C12 (3 x 50 mL). The 
combined organic extracts were washed successively with saturated aqueous NaHC03 
(2 x 100 mL), H20 (2 x 100 mL) and brine (1 x 100 mL). Removal of the solvent in 
vacuo gave a mixture of the formate ester and the free phenol as a cloudybrown gum 
(204 mg). 
In an attempt to hydrolyse the formate ester, the ester (204 mg) was dissolved in a 
mixture of THF (1.7 mL) and methanol (1.7 mL). LiO!I (17.8 mg, 0.423 mmol) was 
added with stirring. After Ih, the brown solution was acidified to pH 6 using 1M 
lICl and the solution diluted with H20 (20 mL). The solution was extracted with 
ethyl acetate (3 x 25 mL) and the combined organic phases were washed with water (2 
x 75 mL) and brine (1 x 75 mL). Removal of the solvent in vacuo gave the title 
dioxane as a yellow gum (203 mg, 1 00%). 
1 HNMR (CDC13)0 7.06 (tH, d, J HH 8.4 Hz, ArH), 6.92-6.96 (UI, m, ArH), 6.75 (d, 
J HH = 8.8 Hz, HI, ArH) 4.41 (dd, JHH 9.3, 12.7 Hz, 2H, ArOCH2), 3.87-4.01 (m, lH, 
ArOCH2CH), 1.35 (s, 3H, H3CCOHCH3), 1.30 (s, 3H, H3CCOHCH3). 
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/3C NMR (CDCI3) 0 144.3, 142.5, 124.3, 120.1, 118.2, 112.8,78.9 70.6 64.7, 25.9, 
25.1. 
FTJR (cm'l, KBr disk) 3440.8, 1585.8. 
HREIMS Calc. for CIIHI303Br: 272.0048; found: 272.0043. 
2-(2,3-epoxy-3-methylbut-2-en -l-yloxy )-5-bromobenzeneformate 2.3 9 
o~ 
~CHO 
Y 
Br 
2.38 
O~ 
~OCHO 
Y 
Br 
2.39 
Benzaldehyde 2.38 (157 mg 0.762 mmol) in CH2Cl2 (1.5 mL) was added to mCPBA 
(57 mg, 0.762 mmol) in a 0.1 M NaH2P04 solution, (0.4 mL). The white suspension 
was stirred for 16h. The reaction was quenched by the addition of the solution to 
satmated aqueous NaHC03 solution (25 mL), which was then extracted with CH2C12 
(3 x 25 mL). The combined organic extracts were washed sequentially with satmated 
aqueous NaHC03 solution (2 x 100 mL) H20 (2 x 100 mL) and brine (1 x 100 mL). 
Removal of the solvent in vacuo gave the crude product as a yellow-brown oil (180 
mg). 
An analytically pure sample was obtained by flash chromatography on silica using 
17.5 % ethyl acetate - petroleum ether as eluant 
J H NMR (CDC13) 0 8.23 (d, J HH 0.98 Hz, IH, ArOCHO) 7.32-7.35 (m, lH, ArH), 
7.24 (s, IH, ArH), 6.93 (d, JHH = 8.8 Hz, ArH), 4.16 (m, lH, OCH2HCOC(CH3)2)' 
4.06 (m, IH, OCH2HCOC(CH3)2)' 3.07 (t, JHH = 5.4 Hz, 4.9 Hz, OCH2HCOC(CH3)2» 
1.36 (s, 3H, OCH2HCOC(CH3)2», 1.32 (s, 3H, OCH2HCOC(CH3)2) 
Chapter 5 - Experimental 99 
J 3C NMR (CDCl]) () 146.9, 144.8, 138.8, 122.8, 113.8, 112.3, 96.7, 68.6, 61.1, 24.6, 
] 9.0. 
HREljVfS Calc. for C12H 130 4Br: 299.9997; found: 299.9990 
FTIR (cm-',KBr disk) 2964,4,1747,4,1494.7 cm-J 
3-Hydroxy-4-(2,3-epoxy-3-methylbut-2-en-l-yloxy )-brom obenzene 2.40 
O~ 
~.~ OCHO Y 
Sr 
2.39 
Sr 
2.40 
The crude material from the above reaction (50 mg) was dissolved in methanol (l0 
mL) and refluxed for 16 hours. The solvent was removed in vacuo to afford the title 
compound 2.40 as a yellow oiL (44 mg, 100%), which was used without further 
purification. An analytically pure sample was obtained by flash chromatography on 
silica using 17.5 % ethyl acetate - petroleum ether as eluant 
1 H NMR (CDCl]) () 7.08 (m, lH, ArH), 6.95 (m, IH, ArH), 6.75 (dd, JHH = 6.8 Hz, 
2.0 Hz, lH, ArH), 4.28 (dd, 7.3 Hz, 3.9 Hz, 1H, OCH2HCOC(CH3)2)' 4.01 (dd, 6.5 
Hz, 4,4 Hz, IH, OCH2HCOC(CH3)2»' 3.17 (q, .!.rm = 4.9 Hz, 2.9 Hz, UI, 
OCH2HCOC(CH3)2)' 1,40 (s, 3H, OCH2HCOC(CH3)2), 1.36 (s, 3H, 
OCH2HCOC(CH3)2)' 
13C NAiR (CDCl,) () 146.9, 144.8, 138.8, 122.8, 113.8, 112.3,96.7, 68.6,61.1,24.6, 
19.0. 
HREIA1S Calc. for C,2H\304Br: 299.9997; found: 299.9990 
fH [ LI fl fjARY 
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FTIR (cm-1IZBr disk) 2964.4, 1747.4, 1494.7 cm- I 
Summary of Lewis acid-catalysed cydisation trials 
~ 0 ~ 0 ~ 0 
rloH 1# rloCHO 1# ~OH 1# 
CHO Br Br 
2.24 2.39 2.40 
All yields were determined by integration of the appropriate signals in lH nmr spectra. 
SnCl4-catalysed cyclisatiol1s of epoxide 2.24 
Conditions Temperatures Time (h) 
SnCl4 added to epoxide solution O°C, 20°C, reflux 45 min 
Epoxide solution added to SnC14 solution O°C, 20°C 45 min 
SnC14 solution added to epoxide solution O°C,20DC 45 min 
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Acid-catalysed cyclisations of epoxide 2.24. 
Method Solvent Temperature % Time 
dioxepin 
0.1 eq CSA into epoxide solution CH2Cl2 20°C <5% 72h 
0.1 eq TFA into epoxide solution CH2Cl2 20°C I <5% 1.5h 
1 eq TF A into epoxide solution THF 20°C 0% 72h 
10 eq 'rFA into epoxide solution CH2Cl2 20°C 15% 24h 
1 eq p-TSA into epoxide solution CH2Cl2 20°C 10% 45 min 
TiCl4 added to epoxide solution THF 20°C <5% 30 min 
2 eq TiC14 to epoxide solution THF 20°C I <5% 30 min 
AlCIJ added to epoxide solution THF 20°C <5% 30 min 
BF3.OEt2 added to epoxide Ether 20"C <10% 60 min 
solution 
TMSOTf added to epoxide THF 20"C <10% 30 min 
solution 
TMSOTf added to epoxide DMSO 20°C <10% 24h 
solution 
LiCI04 added to epoxide solution Ether 20"C < ,12 h 
La(OTf), added to epoxide CH2Cl2 20"C 0% 7 days 
solution J 
Lewis acid-catalysed cyclisations of epoxide 2.40 
Method Solvent Temperature % Time 
dioxepin 
SnCl4 to epoxide solution THF 20"C 10% 30 
minutes 
Ti Cl4 to epoxide solution THF 20°C 5% 30 
minutes 
BFJ .OEt2 to epoxide solution ether 20"C 5% 30 
minutes 
2 eq LiCI04 to epoxide solution ether 200C 5% 48 hours 
Chapter 5 - Experimental 102 
Lewis acid-catalysed cyclisations of formate ester 2.39 
Method Solven Temperature % dioxepin Time 
t 
SnC14 to epoxide solution THF 20°C <10% 30 min 
10 eq SnC14 to epoxide solution THF 20°C <10% 30 min 
2 eq LiCl04 to epoxide solution ether 20°C 5% 44h 
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5.2 Experiments described in Chapter 3 
3-Bromo-4-hydroxy-benzaldehyde 3.16 82 
OH 
¢ 
CHO 
3.11 
A solution of 4-hydroxybenzaldehyde 3.11 (1.231 
OH 
~Br y 
CHO 
3.16 
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9.06 nunol) in CHCl3 (8.9 mL) 
was warmed to 40°C and a solution ofBr2 (535 ilL, 10.4 mmol) in CHCl3 (22.2 mL) 
added dropwise over 40 min. After a finiher 75 min of heating, the pale orange 
solution was poured into H20 (50 mL). The aqueous phase was extracted with CHCI, 
(3 x 50 mL) and the organic extracts were combined and washed with H20 (2 x 100 
mL) and brine (1 x 100 mL). The solvent was removed in vacuo to give a cream 
solid. (1.883 g). Purification by flash chromatography on silica, using 25% ethyl 
acetate - petroleum ether as eluant, gave the title compound (1.570 g, 86%). 
1 H NMR (CDCI3) 8 9.83 (s, 1H, ArCHO), 8.04 (d, JHJ:[ 2.0 Hz, 1H, ArH), 7.77 (dd, 
J 1-1H = 6.4, 1.9 Hz, IH, ArH), 7.15 (d, JHJ:[ = 8.9 Hz, lH, ArH), 6.37 (br s, 1H, ArOH). 
13CNAfR (CDC13)8 189.6, 157.8, 134.2, 131.3,130.8,116.5,111.1, 
m. p. = 124-125 °C (recrystallised from ethyl acetate-hexanes to give white needles,), 
lit. melting point 124°C 
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3-Bromo-4-(2-methyl-but-2-en-1-yloxy)benzaldehyde 3.17 
OH O~ qsr 
1# ... 
qsr 
1# 
CHO CHO 
3.16 3.17 
Benzaldehyde 3.16 (1.409 g, 7.01 mmol) was dissolved in DMF (21.5 mL). K1C03 
(1.066 g, 7.71 mmol). was added in one portion via a solid addition tube. The 
peach-coloured solution was stirred vigorously for 15 min at which time 4-bromo-
2-methyl-but-2-ene (890 jlL, 7.71 mmol) was added over 10 seconds. After 17 h, 
the solution was quenched by the addition of 1M HCl (15 mL). The yellow 
solution was extracted with ethyl acetate (3 x 50 mL) and the combined organic 
phases washed sequentially with H20 (2 x 150 mL) and brine (1 x 75 mL). 
Removal of the solvent in vacuo gave a yellow solid (1.860 g). Purification by 
flash chromatography on silica, using 2S% ethyl acetate - petroleum ether as the 
eluant, gave the aldehyde 3.17 as a solid (1.760 g, 93%). 
104 
1 H (CDC13) 0 9.82 (s, IH, ArCHO), 8.06 (d, J HH 2.0 Hz, IH, ArH), 7.77 (dd, JHH = 
6.5, 2.4 Hz, 1H, ArH), 6.98 (d, JHH 8.9 Hz, IH, ArH), 5.46 (m, 1H, 
OCH2CHC(CH3)2)' 4.68 (d, JHH 4.68, 2H, OCH2CHC(CH3)2), 1.79 (d, JJ1H = 2.0 Hz, 
OCH2CHC(CH3)2), 1.76 (s, 3H, OCH2CHC(CH3)2)' 
Be NMR (CDCI3) 0 189.5,160.0,139.2,134.4,131.0,130.0,118.3,113.0,112.7, 
66.5,25.8, 18.4. 
HREIMS calc. for C12H130 2Br: 268.0099; found 268.0094. 
m.p. 41-42°C 
FTIR (em-I, CHC13) 3024.0,1693.4,1593.1 
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3-Bromo-(2,3-dihydroxy-3-methylbut-l-yloxy)benzaldehyde 3.18 
O~ 
~Br y 
CHO 
3.17 
CHO 
3.18 
105 
The alkene 3.17 (4.095 g, 15.2 mmol) was dissolved in acetone (2.0 mL) and the 
resulting yellow solution was to a solution ofN-methylmorpholine-N-oxide (1.868 g, 
16.1 mmol) and osmium tetroxide (38mg, 0.15 mmol) in H20 (7.90 mL), acetone (0.5 
mL) and teli-butanol (0.6 mL). The solution immediately blackened upon substrate 
addition. After 21.5 hours, a slurry of sodium sulfite (250 mg), H20 (20 mL) and 
magnesium silicate (3 g) was added. The resulting suspension was stirred for 15 min 
and filtered. The brown residue was rinsed with ethyl acetate (125 mL) and the pH of 
the resultant light brown filtrate adjusted to pH 2 using 1M HCI solution (15 mL). 
111e yellow organic fraction was washed with successive portions of H20 (2 x tOO 
mL) and brine (1 x 100 mL). The solvent was removed in vacuo to yield a golden 
liquid. Azeotropic distillation with 100 mL of 4:1 hexanes/ether in vacuo gave the 
title compound 3.18 as a brown solid (4.020 g, 87%) which was used without further 
purification. 
An analytically pure sample was obtained by flash chromatography on silica using 
60% ethyl acetate - petroleum ether as eluant. 
1 H NlvlR (CDC1]) 89.85 (s, HI, ArCHO), 8.08 (d, lH, JIlli = 1.9 Hz, ArH), 7.8 (dd, 
J HH 6.7 Hz, 1.9 Hz, lH, ArH), 7.03 (d, IH, JIlli 8.3 Hz, ArH), 4.33 (dd, ~IH = 6.4 
Hz, 2.7 Hz, lH, ArOCH2CHOH), 4.19 (dd, JIlli = 6.3 Hz, 2.9 Hz, lH, 
ArOCH2CHOH), 3.86 (dd, JIlli 6.4 Hz, 2.9 Hz, tH, ArOCH2CHOH), 3.05 (br s, lH, 
OH), (bI' s, IH, OH), 1.35 (s, lH, H 3CCCH3), 1.32 (s, IH, H3CCCH3)' 
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J3C NMR (CDCU 8 189.48, 159.35, 134.31, 131.16, 131.00, 112.83, 112.50,75.05, 
74.97, 71.68, 70.90, 70.78, 26.52, 25.48 
FTIR (cm'l, CHCI,) 3317.3, 2972.1,1666.4,1595.0. 
HREIMS Calc. for C12H1504Br: 302.0154; found 302.1033 
m.p. 93-94 °C (yellow plates) 
3-B romo-4-(3-hydroxy-2-benzyl-3-methyl-butyI-1-oxy )benzaldehyde 3.20 
O~OH q Br OH ~. 1# 
CHO 
3.18 
O~H 
ArBrOBn y 
CHO 
3.20 
Diol 3.18 (752 mg, 2.48 mmol) was dissolved in THF (12.5 mL) and the yellow 
solution was cooled to o°c. Potassium tert-butoxide (279 mg, 2.48 mmol) was added 
via solid addition tube. The solution was stirred vigourously for 5 minutes, at which 
time benzyl bromide (295 J..LL, 2.48 mmol) was added dropwise over one minute. The 
apricot-coloured solution was stirred for 14 hours and quenched by the addition of 
H20 (lOOmL). The aqueous phase wa<; extracted with ethyl acetate (3 x 100 mL) and 
the combined organic extracts were washed with H20 (2 x 150 mL) and brine (1 x 100 
mL). Removal of the solvent in vacuo gave a yellow solid (827 mg), which was 
purified by flash chromatography, using 35% ethyl acetate-petroleum ethers as the 
eluant, to give the title compound 3.20 as a brown gum (81 mg, 9%). 
1 H NMR (CDCI)) 8 9.89 (s, tH, ArCHO), 8.12 (s, IH, ArR), 7.81 (q, JHH 6.8, IH, 
10.7 Hz, ArH), 7.38-7.30 (m, 5H, CH2ArH), 7.01 (d, J HH = 8.5 Hz, 1H, ArH), 5.08 (d, 
J IIIi 8.3 Hz, IH, OCH2ArH), 4.75 (d, J HH 8.3 Hz, lH, OCH2ArH), 4.38-4.42 (m, 
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1H, CH2HCOCH2Ar), 4.28-4.22 (m, 1H, CH2HCOCH2Ar), 3.76-3.80 (m, 1H, 
CH1HCOCH2Ar), 1.33 (s, 3H, COH(CH3)2)' 1.29 (s, 3H, COH(CH3)2)' 
13C NMR (CDC13) 8 189.5 (ArCHO), 159.8 (ArCOCH2), 137.5 (CH2Ar) 134.5 
(ArH), 131.1 (ArH), 130.8 (ArH, 128.5 (ArCH2), 128.4 (ArCH2), 127.5 (ArCH2), 
112.8 (ArH), 112.1 (ArBr) 83.5 (CH2HCOCH2Ar) 71.9 (H3CCOHCH3), 70.4 
(CH2HCOCH2Ar) 74.9 (CH2HCOCH2Ar), 25.1 (H3CCOHCH3), 26.0 (H3CCOHCH3). 
HREIMS calc. for C19H21 0 4Br: 392.0528; found 392.0521. 
FTIR (em", CHC13) 3014.4, 1600.4. 
Additionally, the regioisomerie tertiary benzyl ether 3.21 was also isolated (271 mg, 
29%). 
1 H NMR (CDC13) 8 9.84 (lH, s, ArCHO), 8.07 (d, lH, JHH = 2.5 Hz, ArH), 7.77 (d, 
1H, ~1H = 1.9 Hz, ArH), 7.73 (d JHH = 1.9 Hz, 1H, ArH) 7.34-7.22 (m, 5H, 
OCH2ArH), 4.53 (s, 2H, OCH2Ar), 4.40-4.53 (m, 1H, CH2HCOCH2Ar), 3.89-3.93 (m, 
2H, CH2HCOCH2Ar), 3.73-3.68 (m, 2H, CH2HCOCH2Ar), 1.33 (s, 6H, COH(CH3)2)' 
13C NMR (CDC13) 8 189.6 (CHO) 160.1 (ArO), 137.4 (H2CArH), 134.6 (ArH), 
134.4 (ArH), 131.1 (ArH), 131.0 (ArH), 128.5 (ArH), 127.9 (ArH), 127.6 (ArH), 
116.6 (ArH), 115.1 (ArH), 113.6 (ArBr), 85.8, (CH2HCOHCOCH2Ar), 73.7 
(OCH2Ar), 72.2 (HCCOCH2Ar), 69.7 (OCH2CHOH) 25.8 (COH(CH3)2' 25.5 
(COH(CH3)2' 
HREIMS Calc. for C19H2104Br: 415.0521; found 415.0528. 
FTiR (em'l, CHC13) - 3014.4,1600.4. 
3-Bromo-4-(tert-butyldimethylsilyl)-3-methyl-butyl-1-oxy)benzaldehyde 3.2288 
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O~H 
~ OH ~ Br ~ Br 
1# .. 1# 
CHO CHO 
3.18 3.22 
Diol 3.18 (483 mg, 1.59 mmol), imidazole (308 mg, 2.39 mmol), tert-
butyldimethylsilylchloride (264 mg, 1.75 mmol) and N,N-dimethylaminopyridine (39 
mg/O.32 nIDlol) were added to a pear-shaped flask and DMF (440 ~L) was added 
drop wise. During the addition, the flask was gently heated with a heat gun. The 
resulting yellow viscous solution was stined for 34h. The cloudy yellow suspension 
was added to a Na2HPO/NaH2P04 buffer (20 ml, pH 7.4) and the aqueous phase 
was extracted with ethyl acetate (3 x-50 mL). the combined organic phases were 
washed with H20 (2 x 100 mL) and brine (1 x 100 mL). The solvent was removed in 
vacuo to give a yellow oil (480 mg). This was purified by flash chromatography, 
using 35% ethyl acetate petroleum ether as eluant, to give the title alcohol 3.22 as 
colourless crystals (226 mg, 34%) and the starting diol (250 mg). The regiochemistry 
of the alkylation was confirmed by single-crystal-ray analysis. Details of which can 
be obtained from the author. 
1 H NMR (CDCI]) 0 9.84 (s, IH, ArCRO), 8.08 (d, JHH 1. 9Hz, IH, ArR), 7.80 (dd, 
J HH 2.1, 0.7 Hz, IH, ArR), 6.99 (d, JHH 8.8 Hz, 1H, ArR), 4.23 (m, 1H, 
ArOCH2CHOH), 4.06 (m, 1H, ArOCH2CROH), 3.86 (dd, JHH = 6.4 Hz, 2.9 Hz, 1H, 
ArOCH 2CHOH), 1.28 (s, 6H, CH2C(CH3)2), 1.26 (s, 3H, OSiC(CI-I3)3CH3)' 0.91(s, 
9H, OSiC(CH3)3CH3)' 
13e NMR (CDCl3) 0 189.5, 159.7, 134.7, 131.1, 112.3, 76.6, 72.3, 71.6, 25.9, 25.8, 
25.7, 18.2. 
HREIA1S Calc. for C14H2004Si: 359.0314; found 359.0329. 
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FTIR (em-I, CRCl,) 3018.4, 1691.5. 
m.p. = 78-79 °C (recrystallised from ethyl acetate-hexanes to give colourless plates) 
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3-Bromo-4-(3-hydroxy-2-(2-methoxy-methyl ether)-3-methyl-butyl-l-oxy) 
benzaldebyde 3.23 
CHO 
3.18 
CHO 
3.23 
110 
Hunig's base (660 mL, 3.03 mmol) was added dropwise over 30 sec to a solution of 
diol 3.18 (834 2.75 mmol) in CH2Cl2 (28 mL) at O°C. MOMCI (230 ilL, 3.03 
mmol) was immediately added dropwise over 1 minute with the evolution of a white 
gas. TIle light brown solution was warmed to RT and stirred for 14 h. The solution 
was then cooled to O°C and in succession extra Hunig's ba<;e (288 ilL, 1.82 mmol) and 
MOMCI (125 ilL, 1.52 mmol) were added dropwise over 30 seconds. After a further 
24 h of stilTing, the yellow solution was added to saturated aqueous NaHC03 solution 
(50 mL) and the aqueous layer was extracted with CH2C12 (3 x 50 mL). The 
combined organic layers were washed successively with H20 (2 x 100 mL), brine (1 x 
100 mL) and the solvent removed in vacuo to yield a brown solid. Purification by 
flash chromatography on silica 40% ethyl acetate - petroleum ether as eluant, gave the 
title ether 3.23 as a brown solid. (361 mg, 38%). 
1 H NMR (CDCI3)0 9.85 (s, IH, CHO), 8.09 (d, JHH = 1.9 Hz, IH, ArH), 7.81 (dd, JHH 
6.6, 1.9 lH, ArH), 7.01 (d, JHH = 8.3 Hz, IH, ArH), 5.03 (d, JHH 6.9 Hz, IH, 
CHOCH20CH,), 4.83 (d, JHH = 6.9 Hz, HI, ArOCH2CHOCH20CH3), 4.20-4.34 (m, 
IH, ArOCH2CHOCH20CH3), 3.85 (t, JHH = 3.4 Hz, IH, ArOCH2CHOCH20CH3) 3.45 
(s, 3H, CH20CH3), 1.34 (s, 3H, H3CCCH3), 1.31 (s, 3H, H3CCHCH3) 
13(, NJvIR (CDCIJ)8 189.6, 159.8, 134.5, 131.1, 130.8, 113.0,112.6,91.1,77.9,75.5, 
70.5,55.4,23.0,22.5. 
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HREIMS: Calc. for (CI4H190sBr- C2HsO): 298.9938; found; (M+ - C2HsO) 
298.9928. 
FTIR (cm-I, CHCI3) 1697.2,3030.0,3022.2. 
3-Bromo-4-(3-hydroxy-2-keto-3-methyl-butyl-l-oxy)-benzaldehyde 3.19 93 
O~H q Br OH I . § 
CHO 
3.18 
O~H 
~BrO y 
CHO 
3.19 
N-l11ethyIl11orpholine-N-oxide (35 mg, 0.296 mmol), freshly-powdered activated 4 A 
sieves and tetrapropylammonium perruthenate (3.5 mg, 0.010 mmol) were added to a 
solution of diol 3.18 (59.7 mg, 0.197 mmol), in CH2Cl2 (0.4 mL) via a solid addition 
tube. The resultant dark green suspension was stirred vigorously for 2 h and put 
through a 2 cm silica plug eluting with ethyl acetate (50mL). Removal of the solvent 
in vacuo gave a brown gum, which hardened upon contact with air. This was purified 
by flash chromatography, using 40% ethyl acetate - petroleum ether as eluant, gave 24 
l11g of the title ketone 3.19 (41%) as a yellow solid and 35 mg of the starting diol. 
IH NMR (CDCI3)8 9.85 (lH, s, ArCHO) 8.11 (d, J= 3.4 Hz, 1H, ArH), 7.78 (dd, JHH 
= 6.4 Hz, 1.9 Hz, 1H, ArH) 6.81 (d, JHH = 8.3 Hz, lH, ArH), 5.18 (s, 1H, 
ArOCH2CO), 1.51 (s, 1H, COC(CH3)2)' 
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13C NMR (CDCI)) (5 207.4,189.6, 160.4, 158.9, 134.9, 134.6, 131.2,131.0, 113.0, 
112.4, 77.0, 70.l, 26.8. 
m.p. 108-11ODC (recrystallised from ethyl acetate-hexane to give stout lemon rods) 
FTIR (em-I, CHC13) 3386.8,2972.1, 1681.8, 1585.4. 
HRE1MS Calc. for CI2H130 4: 301.9978; found; 301.9981. 
4,4-dimethyl-3-oxo-3,4-dihydro-2H-benzo-[b ]-[1,4 ]-dioxepin-7 -carbaldehyde 2.29 
O~H 0 O~ ~BrO qo 1# )lIDo 1# 
CHO CHO 
3.19 2.29 
An oven-dried, filtered Schlenk flask was charged with Pd(OAc)2 (2.5 mg, 0.013 
mmol), Tol-BINAP (9.2 mg , 0.014 mmol), K2C03 (37.2 mg , 0.271 mmol) and the 
ketol 3.19 (68 mg, 0.225 mmol). The solid mixture was dissolved in toluene (2.25 
111L) and heated to 100°e. After 24 h, the reaction was cooled to 25°C and taken up in 
ethyl acetate (lOmL), The solution was put through a silica plug (10 g), eluted with 
further ethyl acetate (30 mL) and the solvent removed in vacuo to give the crude 
product (l1 0 mg). This was purified by flash chromatography on silica using 40% 
ethyl acetate - petroleum ether as eluant, gave the title compound 2.29 (3 mg, 6%), 
which gave identical spectral data to that recorded previously, (see Section 5.2) 
The major product of the reaction (19 mg, 39%) was identified as ketone 3.28, which 
arose from an a-keto I realTangement of3.19. 
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0 OH 
~ lA( ~Br OH )IiiiIo qBr I§ I§ 
CHO CHO 
3.19 3.28 
1 H NMR (CDCl3) (39.83 (s, 1H, ArCHO), 8.06 (d, JHH = 1.9Hz, 1H, ArH), 7.79 (dd, 
JI-II-I = 7.4, 1. 9Hz, 1H, ArH), 6.98 (d, JHH = 8.8 Hz, 1H, ArH), 4.28 (d, JHH = 9.3 Hz, 
IH, ArOCH2), 4.12 (d, J HH = 9.3 Hz, 1H, ArOCH2C), 2.41 (s, 3H, 
CH2CH3COHCOCH3), 1.49 (s, 3H, CH2.CH3COHCOCH3). 
13C NMR (CDC13) (3210.0,189.4,159.0,134.5,131.9,131.2,131.0,112.7,78.0, 
74.2,25.0,21.4. 
FTIR (em-I, CHC13) 3361.7, 1693.4,1612.4. 
HREIMS Calc. for C12H120 4 : 220.0736 ; found: 220.0718. 
General methods for Pd-catalysed aryl ether cyclisations 
All manipulations were performed in a Vacuum Atmospheres glovebox under a zero-
grade Ar atmosphere. All reactions were performed at a concentration of 0.1 M in the 
substrate alcohol. 
Method 1 
An oven-dried Schlenk flask was charged with Pd(OAc)2 (0.03 eq), 
diphenylphosphinoferrocene (0.036 eq), NaOtBu (1.2 eq) and the substrate alcohol. 
This mixture was dissolved in toluene, protected from light and heated to 80°C with 
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stirring. The reaction was monitored by thin-layer chromatography and upon 
consumption of the starting material, cooled to room temperature. The crude reaction 
mixture was taken up in 25 mL ethyl acetate, put through a 10 mm silica plug and 
concentrated in vacuo. 
Method 2 
An oven-dried Schlenk flask was charged with Pd(OAc)2 (0.05 eq), Tol-BINAP (0.06 
eq), K2C03 (1.2 eq). A solution of the substrate alcohol in toluene was added, the flask 
was protected from light and heated to 100DC with stirring. The reaction was 
monitored by thin-layer chromatography and upon consumption of the starting 
material, cooled to room temperature. The crude reaction mixture was taken up in 25 
mL ethyl acetate, put through a 10 rum silica plug and concentrated in vacuo. 
Cyclisation trials using Buchwald's cQnditions78 
Substrate Conditions Result 
3.20 1.2 eq NaOtBu, 0.03 eq Pd(OAc )2' 0.036 No reaction 
Bn eq dppf, Toluene, 80°C, 24 hours 
3.20 1.2 eq K2C03, 0.05 eq Pd(OAc)2' 0.06 eq No reaction 
Bn Tol-BINAP, Toluene, 100DC, 36 hours 
3.22 1.2 eq NaOtBu, 0.03 eq Pd(OAc)2' 0.036 No reaction 
TBDMS eq dppf, Toluene, 80DC, 24 hours 
3.22 1.2 eq K2COJ, 0.05 eq Pd(OAc)2' 0.06 eq No reaction 
TBDMS Tol-BINAP, Toluene, 100DC, 36 hours 
3.23 1.2 eq K2C03, 0.05 eq Pd(OAc)2' 0.06 eq No reaction 
MOM Tol-BINAP, Toluene, 100DC, 48 hours 
3.23 1.2 eq NaOtBu, 0.03 eq Pd(OAc)2' 0.036 Dehalogenation of starting 
MOM eq dppf, Toluene, 80DC, 24 hours material 
3.19 1.2 eq NaOtBu, 0.03 eq Pd(OAc)2' 0.036 Destruction of substrate 
Ketone eq dppf, Toluene, 80GC, 24 hours 
3.19 1.2 eq K2COJ , 0.05 eq Pd(OAc)2' 0.06 eq a-ketol rearrangement 
Ketone Tol-BINAP, Toluene, 100DC, 48 hours (39%) 
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Dioxepin formation (7%) 
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